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Abstract  
Synthetic studies towards highly oxygenated seco-prezizaane sesquiterpenes are reported, 
which culminated in a formal total synthesis of the neurotrophic agent (-)-jiadifenolide. 
For the construction of the tricyclic core structure, an unusual intramolecular and 
diastereoselective Nozaki-Hiyama-Kishi reaction involving a ketone as electrophilic 
coupling partner was developed. In addition, synthetic approaches towards the related 
natural product (2R)-hydroxynorneomajucin, featuring a Mn-mediated radical cyclization 
for the tricycle assembly and a regioselective OH-directed C-H activation are presented. 
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Introduction 
Natural products that induce or stimulate neuron differentiation and neurite outgrowth 
have been identified as promising small molecule alternatives to the nerve growth factor 
(NGF), a key protein mediating neuritogenesis in humans.1 Since the early studies of 
Schreiber, Corey, and Danishefsky, many groups, including ours, have investigated small 
molecule neurotrophins.2 The large variety of chemotypes that are able to stimulate 
neurite outgrowth suggests chemical interference with different pathways beyond NGF-
mediated differentiation and outgrowth. While many pathways remain to be discovered, 
chemical synthesis might provide a leading role in mapping out these molecular 
mechanisms of a process central to memory and learning. An interesting class of 
compounds featuring strong activity as small molecule neurotrophins is represented by 
the seco–prezizaane-sesquiterpenes, in particular those of the majucin-type (Figure 1).3 
Several such compounds have been shown to be neurotrophically active,4 such as 
jiadifenin (1),5 (-)-jiadifenolide (2), (2S)-hydroxy-3,4-dehydroneomajucin (3),5 
jiadifenoxolane A (4)6 and the norsesquiterpenoid (2R)-hydroxy-norneomajucin (5).7 
Furthermore, also the synthetic carboxylic acid derivative of jiadifenin (6) showed potent 
neurite outgrowth promoting activity in primary cultured rat cortical neurons.3b Biological 
studies on jiadifenolide (2) suggested that the observed neuronal dendritic outgrowth 
might involve MAP2 AND PSD95 proteins,[Kuzahara, Biochemical and Biophysical 
Res. Comm 2016, 470, 798] and Shenvi raised the possibility that jiadifenolide might 
interact with the Cys-loop family of ion channels based on structural similarity to 
picrotoxinin [Shenvi Nat.Prod.Rep.,2016,33, 535].  
Figure 1. Neurotrophic seco-prezizaane-sesquiterpenes natural products. 
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The structurally complex framework of these terpenoids combined with their potent 
biological activity renders these compounds interesting targets for synthetic studies. A 
number of successful total syntheses have been reported for both jiadifenin (1)8 and 
jiadifenolide (2),9 culminating in the impressive eight-step, gram-scale synthesis of the 
latter compound by Shenvi and co-workers.10 Our research group has been working 
towards this family of compounds over the past few years,11 and in this publication, we 
report synthetic studies towards seco-prezizaane type sesquiterpenes, and a formal total 
synthesis of (-)-jiadifenolide (2), in full detail. 
 
 
Results and Discussion 
(-)-Jiadifenolide (2) is a highly oxygenated sesquiterpene featuring a unique seco-
prezizaane-type skeleton. Reported strategies for the assembly of the ABC-ring system8a-d, 
9a-b involve formation of the rings in the order BàABàABC, AàABàABC, and 
CàBCàABC. So far B-ring cyclization from an AC-ring system is known to proceed via 
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samarium-mediated cross-coupling9c-d or via tandem Tsuji-Trost/lactonization reaction.8e 
We envisioned a novel strategy by building up the B-ring via cyclization of the AC-ring 
system, where the A-ring is originally derived from readily available (R)-pulegone via 
methylester 712 and the C-ring from tetronic acid (Scheme 1). For the connection of the 
A- and C-ring we envisioned a Knoevenagel condensation in order to form the AC-ring 
fragment.2f The key step, viz. the aforementioned formation of the B-ring, was supposed 
to be performed by a Nozaki-Hiyama-Kishi (NHK) coupling.13 The remaining methyl 
group at the quaternary stereogenic center C-5 was planned to be installed via 1,4-
addition to the unsaturated γ-lactone, or a two-step procedure including Corey-
Chaykovsky cyclopropanation and subsequent Birch reduction.14 The bridged D- and E-
ring was planned to be constructed by ester reduction and C1-homologation.15 
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Scheme 1. Retrosynthetic analysis of (–)-jiadifenolide. 
 
Methylester 7 was synthesized according to a literature procedure12 in two steps starting 
from inexpensive (R)-pulegone. Subsequent allylation of 7 yielded compound 8 in good 
yield (92%) and diastereomeric ratio (11:1 in favor of the desired isomer, Scheme 2). 
Ozonolysis furnished the aldehyde 9, which was coupled to tetronic acid with Hantzsch 
ester as reducing agent,16 yielding the AC-ring fragment 10 in 81% yield. Triflation of the 
enol 10 led to vinyltriflate 11, which was treated under NHK reaction conditions.13 
Pleasingly, diastereoisomer 12 was exclusively formed in 69% yield, and its constitution 
and configuration was subsequently confirmed by X-ray crystal structure analysis.  
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Scheme 2. Synthesis of the tetracyclic precursor. 
  
Reagents and conditions: (a) NaH, THF/DMPU (4:1), rt, 1 h, then allyl bromide, 0 °C, 13 h, 92%, dr = 
11:1; (b) O3, CH2Cl2/MeOH (5:1), –78 °C; Zn, AcOH, –78 °C to rt, quant.; (c) Tetronic acid, Hantzsch 
ester, L-proline (10 mol%), MeOH, 24 h, rt, 81%; (d) 2,6-Lutidine, Tf2O, CH2Cl2, –78 °C to rt, 7 h, quant.; 
(e) CrCl2, NiCl2 (10 mol%), 3 Å MS, DMF, 50 °C, 24 h, 69%; (f) BH3.DMS, THF, 2.5 h, 0 °C to 45 °C, 
76%; (g) KCN, THF/H2O (1:1), rt, 2 d, 65%. 
The next challenge was to find an appropriate reducing agent for the transformation of 
the methylester 12 to the corresponding aldehyde, and to install the D-ring later. The use 
of LiAlH4 proved to be too harsh as several products were detected by NMR analysis of 
the reaction mixture after work-up, whereas reaction with NaBH4 in ethanol at 60 °C and 
superhydride (LiEt3BH) in THF at 0 °C selectively reduced the lactone moiety, while the 
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methylester remained intact. However, we were very pleased that reduction with borane 
dimethyl sulfide was found to give aldehyde 13 in 76% yield, and initially expected over 
reduction to the corresponding diol did not take place. For the introduction of the second 
g-lactone, we planned to install the C-11 carbon by cyanide addition followed by 
hydrolysis and lactonization. Cyanidation with TMSCN and Et3N did not lead to the 
desired product.17 Potassium cyanide in aqueous THF solution transformed the aldehyde 
13 to the tetracyclic dilactone 14 as a single diasteroisomer (65% yield) and the expected 
cyanohydrin was not observed. The close juxtaposition of the neighboring C-4 hydroxy 
group to the putative cyanhydrin intermediate could facilitate formation of the 
corresponding imidate. As the reaction is conducted in aqueous organic solvent, the imine 
is prone to undergo hydrolysis to form the a-hydroxy lactone 14. However, the exact 
mechanism for this observation remains unclear, as multiple other factors might be 
involved. Regarding the stereoselectivity, diastereoselective nucleophilic attack of the 
cyanide to the aldehyde would explain the configuration observed. However, also here a 
mechanism involving both epimeric cyanohydrins can be reasoned, which would be in 
equilibrium with the aldehyde 13, and subsequently, only one diastereoisomer would 
react to the thermodynamic product 14. Isomerization of the hydroxyl group due to steric 
effects with the proximate methyl group at C-1 would also be possible, but rather 
improbable due to the poor acidity at the C-10 position. To the best of our knowledge, 
this is the first kind of reaction sequence featuring a cyanohydration followed by 
hydrolysis and g-lactonization. While this route proved to be effective in installing the 
ABCD ring system of these natural products, installation of the missing quaternary 
methyl function on the tetracyclic structure 14 was challenging. 1,4-Addition18 using 
various conditions and Corey-Chaykovsky cyclopropanation appeared to be completely 
unreactive. We assumed that the D-ring lactone in butenolide 14 might be too sterically 
demanding or influenced the shape of the molecule, rendering a nucleophilic attack at the 
appropriate position not feasible. In order to test this hypothesis, we applied the 
conditions evaluated above on the simpler ABC-ring fragment (Scheme 3). Tertiary 
alcohol 12 was treated with Burgess reagent and the obtained trisubstituted olefin 15 was 
dihydroxylated to diol 16. Once again, no reactivity towards cuprate addition19 as well as 
Corey-Chaykovsky conditions14 was observed for both substrates 12 and 16. 
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Additionally, Simmons-Smith conditions20 were tested on the diol 16, but even with the 
allylic hydroxy group serving as a directing group,21 we were not able to cyclopropanate 
the butenolide moiety. 
Scheme 3. Methylation attempts on various substrates. 
 
Reagents and conditions: Burgess reagent, THF, rt, 3.5 h, 93%; (b) OsO4 (5 mol%), NMO, t-BuOH/H2O 
(3:1), 0 °C to rt, 3 d, 84%, dr = 10:1. 
 
Sampson and co-workers described a similar scenario and attributed the lack of reactivity 
to a competitive γ-deprotonation pathway, which affords an aromatic furan oxide rather 
than the conjugate addition.14 In order to avoid the reactivity issues for the C-5 
methylation we focused on a temporary opening of the A-ring to overcome reactivity 
issues in this critical methyl group insertion (Scheme 4).  
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Scheme 4: Synthesis of the aldehyde fragment. 
 
Reagents and conditions: (a) Rh/C/Al2O3 (10 mol%), H2 (60 bar), EtOAc, rt, 3 h, quant.; (b) NaIO4, 
THF/H2O (2:1), rt, 1.5 h, quant.; (c) ethylene glycol, p-TSA.H2O, benzene, 90 °C, 2 h, quant.; (d) formaline, 
THF, pH 6, 40 °C, 14 h, 94%; (e) PPh3, imidazole, I2, benzene, rt, 12 h, 75%; (f) n-Bu3SnH, AIBN, 
benzene, 85 °C, 3 h, 84%; (g) 1 M HCl, acetone, rt, 14 h, 99%; (h) NaBH(OCH(CF3)2)3, hexafluoro-2-
propanol, rt, 16 h, 85%; (i) PPh3, imidazole, I2, benzene, rt, 16 h, 95%; (j) SmI2, HMPA, THF, rt, 1 h, 76%; 
(k) BH3.DMS, THF, 2.5 h, 0 °C to 45 °C, 66%. 
 
Olefin hydrogenation on the diol 16 was carried out successfully in quantitative yield in a 
diastereoselective fashion and the configuration of the hydrogenated product 17 was 
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confirmed by X-ray crystal structure analysis.22 The A-ring was then cleaved by oxidation 
to the unstable ketoaldehyde 18 using sodium periodate23 and protected to obtain the 
corresponding acetal 19 in quantitative yield. Since methylation of compound 19 did not 
yield the desired product due to decomposition under basic (MeI with DBU or LDA) and 
acetal deprotection under acidic conditions, we performed a hydroxymethylation under 
neutral conditions to install the additional C-5 carbon on substrate 19. The stereochemical 
outcome of the reaction was verified by 2D-NMR studies. Hydroxymethylation was 
expected to be stereospecific due to the formation of the thermodynamically favorable 
cis-fused bicyclic ring system.24 A Garegg-Samuelsson iodination of the OH group in 
compound 20, followed by radical dehalogenation of the resulting iodide 21 using 
tributyltin hydride gave the methylated intermediate 22. The acetal was hydrolized under 
acidic conditions to form the aldehyde 23. Reduction of 23 using NaBH4 was not 
reproducible, but sodium tris(hexafluoroisoproopoxy)borohydride, reported as a very 
mild reducing reagent,25 was found to be efficient (85%). Primary alcohol 24 was 
subsequently iodinated applying Garegg-Samuelsson conditions and the structure of the 
resulting iodide 25 was confirmed by X-ray crystal structure analysis. First attempts to 
close the A-ring using organolithium reagents resulted in complex mixtures (n-BuLi)26 or 
formation of minor amounts of 26 (t-BuLi).2e Finally, SmI2 mediated ring closing using 
HMPA as an additive, which was found to be crucial, gave the desired tricycle 26 as a 
single diastereomer in a remarkable yield of 76%.27 We were pleased that the borane 
dimethyl sulfide mediated reduction applied earlier on ester 12, was reproducible for 
intermediate 26 to yield the desired aldehyde 27 in 66%. 
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Our initial established strategy for the C1-homologation on the aldehyde 27 was resumed 
to produce the tetracyclic structure 28 (Scheme 5). Selenoxide promoted elimination28 
then formed an a,b-unsaturated intermediate which under the applied reaction conditions  
cyclized to form the E-ring containing lactone 29. Oxidation of lactone 29 in the presence 
of H2O2 led directly to pentacycle 33. Unfortunately, the pentacycle 33 had shown to be 
completely unreactive towards the final installation of the hydroxyl-group at C-10 using 
various oxidation protocols29 (Scheme 5). Aware of the difficulties accompanied with the 
introduction of this critical hydroxyl group, intermediate 29 was treated under different 
conditions using LiHMDS as base to obtain the a,b-unsaturated lactones 30 or 32, which 
should act as stable precursors for the final E-ring formation. However, treating 
compound 32 under established epoxidation conditions yielded in desilylation and 
subsequent formation of the aforementioned a-hydroxy lactone 33.4b. Studies using the 
more stable TES protecting group led to formation of pentacycle 33 as well. It was thus 
decided to first oxidize the D-ring moiety at C-10 to overcome reactivity issues of 
intermediate 33. We oxidized compound 30 with DMP to the corresponding ketone 31. 
To our disappointment, the same epoxidation conditions culminated in decomposition of 
the starting material. Presumably, the electrophilic properties of the ketone dominate over 
the Michael acceptor capability, which results in decomposition of the starting material.  
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Scheme 5: Synthetic approaches towards (-)-jiadifenolide 
 
Reagents and conditions: (a) KCN, THF/H2O, rt, 3 d (63% over two steps); (b) LDA, PhSeBr, H2O2, THF, 
–78 °C to 0 °C, 1.5 h, 48%; (c) LiHMDS, –78 °C to rt, 2 h, n.d; (d) DMP, CH2Cl2, rt, 16 h, n.d.; (e) 
LiHMDS, TMSCl, THF, –78 °C to 0 °C, 1 h, n.d.; (f) NaOH, H2O2, MeOH/THF (3:1), 0 °C to rt, 14 h. 
 
As the introduction of the quaternary methyl group at C-5 proved cumbersome, and was 
only solved by a lengthy route, we directed our attention to alternative approaches 
towards the construction for the ABC-ring intermediate along with an earlier installation 
of this critical methyl group. At first, we aimed to construct the A- and B-ring via a 
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diastereoselective inverse electron-demand Diels-Alder reaction or more likely to use a 
stepwise approach by the combination of either 1,4- or 1,6-addition and subsequent aldol 
addition (Scheme 6). 
 
Scheme 6. Retrosynthetic analysis of the AB-ring system. 
 
 
Different strategies involving aldol cyclisation were evaluated. The 1,4-addition adduct 
35 was synthesized by Michael addition of b-ketoester 7 to the literature known30 benzyl 
protected hydroxy ketone 34 using potassium carbonate in acetone with 70% yield and a 
diastereoselectivity of 5:1 (Scheme 7). Neither for the benzyl protected alcohol 35 nor the 
deprotected alcohol 36 an aldol cyclisation took place by using different bases (Cs2CO3, 
KOH, DBU, NaOMe, t-BuOK) or enamine catalysis (pyrrolidine/AcOH, proline). 
Attempts forming the thermodynamic silyl enol ether suitable for Mukaiyama aldol 
reaction from protected β-hydroxy ketone 35 (TMSCl, NaI, NEt3 or TBSOTf, NEt3) or 
trapping the formed enolate after reaction of ester 7 with benzyl protected alcohol 34 
(LDA, then TBSOTf) were not successful either. The α,β-unsaturated aldehyde 38 was 
synthesized by 1,6-addition of ester  7 to the known dienal 3731 with K2CO3 in acetone at 
30°C in 66 % yield.  
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Scheme 7: Synthesis of the AB-ring system. 
 
Reagents and conditions: a) K2CO3, acetone, 40 °C, o.n., 70%, dr = 5:1; b) 5% Pd/C, EtOH, rt, 2.5 
h, quant.; c) K2CO3, acetone, 30 °C, o.n., 66%; d) Me3Al, LiSPh, THF, 0 °C to 40 °C, 37%, dr = 
9:5. 
 
Cyclization of 38 via the enamine did not take place, most likely due to the challenges in 
the isomerization of the conjugated double bond. Nevertheless, the enamine of 38 
(piperidine, AcOH, 105 °C) could be detected via 1H-NMR spectroscopy. In order to 
circumvent the problems accompanied by this double bond we considered using a 
temporary protecting group for this critical functional group. Aldol reaction of aluminium 
enolates generated by 1,4-addition of organoaluminium or organoselenium reagents to 
α,β-unsaturated carbonyl compounds was described by Nozaki.32 Following the 
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cyclization protocol applied for the oxahydrindene fragment from Danishefsky’s 
synthesis of Avermectin A1a,33 we treated aldehyde 38 with the species formed from the 
reaction of trimethylaluminium and lithium thiophenolate. Instead of the desired AB-ring 
product, Michael addition to form a diastereomeric mixture (dr = 9:5) of the 
bicyclo[3.2.1]octanone 39 in 37 % yield was observed. 
 
Scheme 8: Hosomi-Sakurai approach. 
 
Reagents and conditions: a) acrolein, NEt3, CH2Cl2, rt, o.n., 71%; b) isopropenylmagnesium 
bromide, THF, –78 °C, 3 h, 33%; c) vinylmagnesium bromide, THF, –78 °C, 4 h, 42%; d) DMP, 
CH2Cl2, rt, 1 h, quant.; e) DMP, CH2Cl2, rt, 2 h, quant.; f) allyltrimethylsilane, Grubb’s II 
(5 mol%), CH2Cl2, 40 °C, 90 min, 71%; g) allyltrimethylsilane, Grubb’s II (5 mol%), CH2Cl2, 40 
°C, 90 min, 51%; h) PivCl, pyridine, DMAP, CH2Cl2, rt to 40 °C, o.n. crude; i) BnO(NH)CCl3, 
Sc(OTf)3 (5 mol%), CH2Cl2, 0 °C, 90 min, 88%. 
Due to the failure of the cyclization of the B-ring using aldol addition protocols, we 
planned to use a diastereoselective intramolecular Hosomi-Sakurai reaction34 instead 
(Scheme 8). Different strategies to efficiently prepare the allylsilane precursor were 
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evaluated. Attempts to install the TMS group at C-7 using 7 and 2-
(trimethylsilyl)acrylaldehyde or via introduction of the allylsilane part by Grubbs 
metathesis at the C-5 position proved to be unsuccessful. Finally, we were pleased to find 
a route to synthesize test substrates suitable for the Hosomi-Sakurai reaction but with a 
missing methyl group. The synthesis of these substrates started by Michael-addition of 7 
to acrolein, followed by Grignard reaction of isopropenyl- or vinylmagnesium bromide to 
the formed aldehyde 40 to yield 41 and 42, respectively. Cross metathesis using Grubbs 
2nd generation catalyst gave a moderate yield (51%) for the vinyl substrate 42 bearing the 
free alcohol. Higher yields (71%) were observed for the Dess-Martin periodinane 
oxidized substrate 45, however for PMB protected substrate 43 no metathesis product 
was isolated. Neither the free alcohol 41, nor the oxidized substrate 44, derived from the 
reaction of 40 with isopropenyl Grignard reagent, were reactive in the metathesis reaction 
and only homocoupling of allyltrimethylsilane was observed using different reaction 
conditions. The Hosomi-Sakurai reaction was probed on the test substrates 46, 47 and 48, 
but even without bearing the sterically demanding methyl group at C-5 no reaction took 
place.  
 
Scheme 9. Formal synthesis of (-)-jiadifenolide 
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Reagents and conditions: (a) MeMgBr, Fe(acac)3, NMP, THF, –30 °C, 1 h, 96%; (b) SmI2, THF/H2O, rt, 13 
h, 50%, dr = 5:2; (c) BH3.DMS, THF, 6 h, 0 °C to 45 °C, 51%, dr = 5:1. 
 
Zhang and co-workers recently published the protecting group free total synthesis of (-)-
jiadifenolide (2).9d Their synthetic route lead through the same aldehyde intermediate 27, 
which was constructed via a SmI2 mediated closure of the B-ring and formed directly the 
critical methyl function bearing quaternary C-5 stereocenter. Radical cyclization of the B-
ring of substrate 49 was investigated in our group as well, as the approaches to install the 
methyl group on the C ring proved cumbersome. b-Methylated lactone 49 was 
synthesized by applying Fürstner’s conditions to vinyltriflate 11 (Scheme 9). To our 
disappointment, initial evaluation of standard conditions did not facilitate the desired 
cyclization of 49. Reaction with SmI2 in THF without any further additives led mostly to 
the formation of an unidentified side-product at 0 °C as well as at reflux. Additives such 
as HMPA and NiI2 or the addition of protic additives such as MeOH and t-BuOH did not 
lead to the formation of the desired product 26. Given the encouraging results reported by 
Zhang and coworkers on the addition of excess water being crucial for the SmI2-mediated 
radical cyclization, we tested these conditions on the substrate 49. After small adaptions, 
we were able to isolate the desired cyclized product 26 in 50% yield and a diastereomeric 
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ratio of 5:2 (not separable) for C-5. Additionally, a side-product where the keto group 
was reduced to the OH function35 could be isolated in 39% yield (dr 13:1). Treating the 
diastereomeric mixture of 26 with BH3.DMS furnished intermediate 27 in a 
diastereomeric ratio of 5:1 (51% isolated yield) along with recovered starting material 
(15%) in a diastereomeric ratio of 4:3. Concerning the increase of the diastereomeric ratio 
in the transformation from 26 to 27, we suggest that in the minor diastereomer of 26 the 
methyl group at C-5 syn to the ester residue has a steric influence and slows down the 
reduction to the aldehyde. In contrast, a coordination of the butenolide moiety in the 
major diastereomer of 26 to the BH3 might support the reduction to aldehyde 27. In 
summary, aldehyde 27 was obtained from (R)-pulegone in a nine step procedure and an 
overall yield of 10%. 
 
To gain access to a variety of majucin-type sesquiterpenes via derivatization, we targeted 
on a different synthetic approach with involving a similar precursor also represented by a 
common ABC-ring fragment. Manganese induced radical cyclization, already applied in 
our group and successfully utilized in the synthesis of endoperoxides,36 might constitute a 
feasible approach for the construction of the B-ring. Functionalization of the geminal 
methyl functions is present in broad range of seco-prezizaane-type sesquiterpenes. The 
known tetrasubstitued olefin 50 would be an ideal substrate for a regiospecific sp3 C-H 
oxidation of the geminal methyl group, which will be incorporated in the butenolide 
moiety. 
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Starting from enantiopure (R)-pulegone, the known intermediate 50 was readily 
accessible (Scheme 11).12 a-Alkylation attempts using LiHMDS or LDA without 
additives were found to only deprotonate one of the diastereomers, but addition of DMPU 
triggered the reaction to full conversion and the desired alkylated ester 51 was obtained 
as a single diastereomer. The TBS-protecting group was cleaved with TBAF/AcOH and 
the formed alcohol 52 was further oxidized with DMP to the desired aldehyde 53 in 89%. 
A Roskamp reaction37 furnished the desired b-ketoester 54 in an excellent yield of 93%. 
Initial screening for the manganese induced radical cyclization showed formation of the 
desired B-ring. However, the cyclized product 55 was isolated in low yield and along 
with side-products. Raising the temperature to 50 °C could reduce the reaction time but 
byproduct formation was not eliminated. Slow addition of the Mn(OAc)3 or of the 
substrate had no influence and an average yield of 25-30%, with 39% as the best result 
was obtained. The byproducts were only isolated as complex mixtures, suggesting that 
several intermolecular radical recombination reactions occurred. Instead of the excepted 
disubstituted compound, the trisubstituted olefin 55 was directly isolated, which might 
result from chloride elimination. Ketone 55 was reduced in the presence of NaBH4 in a 
complete diastereoselective manner and alcohol 56 could be secured by X-ray 
crystallography analysis. With the desired hydroxy function in hand, a regioselective C-H 
functionalization to form the ether 57 was achieved in the presence of Pb(OAc)4 in 81% 
yield.38 The byproduct 58, bearing an additional acetyl group at the carbon next to the 
ether,39 was further isolated and successfully converted to the desired product 57 using 
BF3.OEt2 and triethylsilane.40 Both structures were confirmed by X-ray crystallographic 
analysis (Scheme 11).  
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Scheme 11. Manganese-mediated cross-reaction to establish the AB-core 
 
Reagents and conditions: (a) LDA, DMPU, THF, tert-butyl(2-iodoethoxy)dimethylsilane,41 –78 °C to rt, 
77%, (b) TBAF, AcOH, CH2Cl2, rt, 16 h, 79%; (c) DMP, CH2Cl2, rt 4 h, 89%; (d) ethyl 2-diazoacetate, 
SnCl2 (cat.), CH2Cl2, 1 h, 93%; (e) Mn(OAc)3, LiCl, AcOH, 50 °C, 5 h, 39%; (f) NaBH4, MeOH, 0 °C to rt, 
4 h, 86%; (g) Pb(OAc)4, cyclohexane, I2, CaCO3, hν, 3 d, 81%; (h) BF3.OEt2, Et3SiH, CH2Cl2, –78 °C to rt, 
15 h, 88%. 
 
To our surprise, the ether bridge was found to be stable under several conditions.42 
Therefore, the chloride 57 was reduced by tributyltin hydride to form the ether 59 in 95% 
yield (Scheme 12). The bridged ether was then opened in the presence of Ac2O and BF3-
etherate43 to give the diacetate 60 along with the elimination byproduct 61, and the acetyl 
groups of 60 were cleaved with K2CO3 in MeOH to form the corresponding diol 62. The 
configuration of the OH group could not be assigned in compound 62, and subsequent 
TPAP-mediated oxidation to the enolaldehyde 63 was carried out. Other oxidation 
conditions furnished enolaldehyde 63 as well, but were found to be not reproducible. 
Conditions using IBX showed traces of the overoxidized a-hydroxylated product 64, 
which indicated a general accessibility of the missing OH function insertion at this stage. 
Nevertheless, the method of choice for the preparation of 64 turned out to be exposure of 
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63 to CeCl3 and molecular oxygen to yield the a-hydroxylated product 64 in 43%.44 A 
reductive cyclization of 64 formed the butenolide and also caused partially closure of the 
D-ring. This mixture was subjected to acid mediated lactonization involving p-TsOH to 
fully promote D-ring formation in compound 65, however in a very low yield of 27% 
over the two steps. Final modifications of the A-ring are proposed in order to give access 
to the natural product (2R)-hydroxynorneomajucin (5) from tetracyle 65. This 
intermediate 65 might also serve as a common precursor to other nor-type seco-
prezizaane sesquiterpenes. 
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Scheme 12. Synthesis of the (2R)-hydroxy-norneomajucin precursor. 
 
Reagents and conditions: (a) Bu3SnH, AIBN, benzene, 100 °C, 2 h, 95%; (b) BF3.OEt2, AcOH, –20 °C to rt, 
12 h, 60%; (c) K2CO3, MeOH, rt, 16 h, 98%; (d) TPAP, NMO, 4 Å MS, CH2Cl2, RT, 16 h, 68%;  (e) CeCl3 
x 7 H2O, O2, i-PrOH, rt, 24 h, 43%; (f) NaBH4, MeOH, 0 °C to rt, 12 h, then p-TsOH, PhMe, 70 °C, μw, 2 
h, 27% (2 steps). 
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Conclusion  
In conclusion, we present a new strategy to access the tricyclic core structure of (-)-
jiadifenolide via a Nozaki-Hiyama-Kishi coupling, which set the stage for an 
diastereoselective, formal total synthesis of the natural product. Due to the challenging 
introduction of the methyl group in order to construct this quaternary stereogenic center 
after the B-ring closure, we elaborated a more efficient route to the tricycle by using a 
SmI2-mediated radical cyclization. Unfortunately, alternative strategies to close the B-
ring using aldol-cyclization protocols or a Hosomi-Sakurai reaction were unsuccessful. 
Furthermore, a C1-homologation promoted by potassium cyanide successfully provided 
the D-ring formation in a remarkable one-step procedure to allow for the completion of 
the synthesis via successive oxidation protocols. Synthetic studies towards (2R)-
hydroxynorneomajucin were carried out, which involved a manganese mediated radical 
cyclization and a regiospecific C-H activation. Moreover, these studies potentially allow 
to access a variety of nor-derivative sesquiterpene natural products as potential 
neurotrophic modulators. 
 
 
 
 
Experimental Section 
General, Materials and Equipment 
All chemicals have been purchased from Acros, Fluka or Sigma-Aldrich and were used 
without further purification (except for Et3N which was freshly distilled before use). All 
reactions have been carried out in heat gun-dried glassware (unless aqueous reagents 
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were used) and reactions involving air sensitive compounds have been performed under 
an argon or nitrogen atmosphere. Solvents applied for chemical transformations were 
either puriss quality or HPLC grade solvents, which have been dried by filtration through 
activated aluminium oxide under nitrogen (H2O content <10 ppm, Karl-Fischer titration). 
For work-up and purification solvents have been distilled from technical grade. All 
synthetic transformations have been monitored by either thin layer chromatography 
(TLC) or 1H NMR spectroscopy. Yields refer to purified, dried and spectroscopically 
pure compounds. TLC was performed on Merck silica gel 60 F254 plates (0.25 mm 
thickness) precoated with fluorescent indicator. Concentration under reduced pressure 
was performed by rotary evaporation at 40°C. Flash chromatography was performed 
using silica gel 60 (230-400 mesh) from SiliCycle or Sigma-Aldrich with a forced flow 
eluent at 0.2-0.4 bar pressure. All 1H and 13C NMR spectra were recorded using a Bruker 
Avance 250 MHz, 400 MHz or 500 MHz (1H) & 63 MHz, 101 MHz or 126 MHz (13C) & 
376 MHz (19F) spectrometer at room temperature. Chemical shifts (d-values) are reported 
in ppm, spectra were calibrated related to solvents’ residual proton chemical shifts 
(CHCl3, d = 7.26; d4-MeOD, d = 3.31) and solvents’ residual carbon chemical shifts 
(CDCl3, d = 77.16; d4-MeOD, d = 49.00), multiplicity is reported as follows: s = singlet, d 
= doublet, t = triplet, q = quartet, m = multiplet or unresolved and coupling constant J in 
Hz. IR spectra were recorded on a Varian 800 FT-IR ATR Spectrophotometer or a Perkin 
Elmer SpectrumTwo ATR-FTIR. The absorptions are reported in cm−1. All masses 
spectra (HRMS-ESI) were recorded by the Mass spectrometric Service of the University 
of Bern on Sciex QSTAR Pulsar mass spectrometer using electrospray ionization, 
University of Basel on a QTOF-ESI Spectrometer (bruker maXis 4G) or University of 
Zürich using a high-resolution mass spectra acquired on a QExactive instrument (Thermo 
Fisher Scientific, Bremen, Germany) equipped with a heated electrospray (ESI) 
ionization source and connected to a Dionex Ultimate 3000 UHPLC system. Melting 
points (M.p.) were determined using a Büchi B-545 apparatus in open capillaries and are 
uncorrected. Optical rotations ° 𝛼 #$  were measured at the sodium D line using a 1 mL 
cell with a 1 dm path length on a Jasco P-2000 digital polarimeter and the concentration c 
is given in g/100 mL and the used solvent is CHCl3. Elementary analysis were performed 
at the University of Basel. X-ray analysis: Data collection for the crystal structure was 
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performed at low temperature using Mo Ka radiation on a Bruker KappaAPEX 
diffractometer. Integration of the frames and data reduction was carried out using 
APEX2.45 The structures were solved by direct methods using SIR92.46 All non-hydrogen 
atoms were refined by full-matrix least-squares on F using CRYSTALS.47 Hydrogen 
atoms were placed in calculated positions by means of the “riding” model. 
 
Methyl (2R)-2-methyl-5-oxocyclopentane-1-carboxylate (7): Methyl (2R)-2-methyl-5-
(propan-2-ylidene)cyclopentane-1-carboxylate21 (360 mg, 1.98 mmol, 1 eq.) was 
dissolved in MeOH (20 mL) and CH2Cl2 (100 mL) at –78 °C. Ozone was bubbled in the 
solution until the solution became light blue. Ozone addition was stopped and the 
solution was stirred under argon at –78 °C for 15 min and at rt for 10 min. Zinc powder 
(526 mg, 7.96 mmol, 4.0 eq.) and acetic acid (0.46 mL, 7.96 mmol, 4.0 eq.) were added 
to the solution. The resulting mixture was stirred at rt for 30 min and filtered over celite. 
The filtrate was neutralized with saturated NaHCO3 solution and the aqueous layer was 
extracted two times with CH2Cl2. The combined organic layers were washed with water 
and brine, dried over Na2SO4, filtered and evaporated under reduced pressure to afford 
ketone 7 (300.6 mg, 1.92 mmol, 97%) as colorless oil: Rf = 0.13 (pentane/Et2O 9:1); 𝛼 #%&	= +93.5 (c 0.46, CHCl3). FTIR (neat); ν = 2959, 2875, 1754, 1724, 1436, 1335, 
1289, 1260, 1202, 1128, 1006 cm-1; 1H NMR (400 MHz, CDCl3) δ = 3.76 (s, 3H), 2.77 (d, 
J = 11.4 Hz, 1H), 2.67−2.53 (m, 1H), 2.48−2.39 (m, 1H), 2.38−2.26 (m, 1H), 2.20 (dddd, 
J = 12.7, 8.3, 6.2, 2.0 Hz, 1H), 1.48 (dtd, J = 12.6, 11.2, 8.5 Hz, 1H), 1.18 (d, J = 6.5 Hz, 
3H); 13C NMR (101 MHz, CDCl3) δ = 212.0, 169.7, 63.1, 52.5, 38.9, 36.5, 29.5, 19.4; 
elemental analysis calcd for C8H12O3: C = 61.52; H = 7.74; N = 0.00; found: C = 61.49; 
H = 7.60; N = 0.00; HRMS (ESI) m/z calcd for C8H13O3 [M + H]+: 157.0859, found: 
157.0861. 
 
Methyl (1R,2R)-1-allyl-2-methyl-5-oxocyclopentane-1-carboxylate (8): Ketone 7 (1.00 g, 
6.4 mmol, 1.0 eq.) was dissolved in dry THF (14.0 mL) and freshly distilled DMPU (3.6 
mL). Sodium hydride (60% dispersion in mineral oil, 307 mg, 7.7 mmol, 1.2 eq.) was 
added at rt and the grey suspension was stirred for 1 h after which it turned to a yellow 
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solution. Allyl bromide (0.67 ml, 7.7 mmol, 1.2 eq.) was added at 0 °C and the milky 
mixture was stirred for 1 h at 0 °C before it was allowed to warm up to rt. After 12 h the 
mixture was diluted with Et2O (20 mL) and washed three times with water. The aqueous 
layers were re-extracted twice with Et2O. The combined organic layers were dried over 
Na2SO4, filtered and evaporated under reduced pressure. Both diastereoisomers were 
separated by chromatography (pentane/Et2O 9:1) giving the desired allylated compound 8 
(1.06 g, 5.4 mmol, 84%) as colorless oil; Rf = 0.48 (pentane/Et2O 4:1); 𝛼 #%) = +38.4 (c 
0.25, MeOH); FTIR (neat);  ν = 3079, 2958, 2882, 1749, 1731, 1434, 1227, 1187, 1165, 
998, 919 cm-1; 1H NMR (400 MHz, CDCl3) δ = 5.56–5.67 (m, 1H), 5.09–5.13 (m, 1H), 
5.08 (s, 1H), 3.69 (s, 3H), 2.66 (dd, J = 14.2, 6.2 Hz, 1H), 2.47–2.58 (m, 2H), 2.27–2.38 
(m, 1H), 2.00–2.18 (m, 2H), 1.72–1.84 (m, 1H), 1.02 (d, J = 6.9 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ = 216.2, 171.1, 133.2, 119.6, 63.1, 52.0, 39.1, 38.7, 35.8, 28.3, 15.6; 
elemental analysis calcd for C11H16O3: C 67.32; H = 8.22; found: C 67.29; H = 8.20; EI-
MS 70 eV, m/z (%) = 196.1 (22, M+), 168.1 (100), 136.1 (63), 109.1 (90), 81.1 (68).  
 
Methyl (1R,2R)-2-methyl-5-oxo-1-(2-oxoethyl)cyclopentane-1-carboxylate (9): Alkene 8 
(2.50 g, 12.8 mmol, 1.0 eq.) was dissolved in a CH2Cl2/MeOH mixture (30 mL, 5:1) and 
cooled down to –78 °C. Ozone was bubbled through the stirring mixture until it turned 
slightly blue. The addition of ozone was stopped and the solution was stirred for 
15 minutes at –78 °C during which time the mixture turned colorless again. Zinc powder 
(3.36 g, 51.0 mmol, 4.0 eq.) and acetic acid (2.6 mL, 51.0 mmol, 4.0 eq.) were added. 
The resulting mixture was allowed to warm up to rt overnight. The mixture was filtered 
over celite and washed with CH2Cl2. After evaporation of the solvent, the residue was 
suspended with CH2Cl2, filtered, and evaporated again to give aldehyde 9 (2.54 g, 12.8 
mmol, quant.) as colorless oil; Rf = 0.68 (pentane/Et2O 9:1); 𝛼 #%)	= +16.4 (c 0.51, 
MeOH); FTIR (neat): ν = 2959, 2881, 2857, 2746, 1749, 1717, 1629, 1599, 1456, 1435, 
1401, 1397, 1350, 1326, 1233, 1217, 1197, 1167, 1126, 1059, 1038, 1006, 904, 759 cm-1; 
1H NMR (400 MHz, CDCl3) δ = 9.66 (d, J = 0.5 Hz, 1H), 3.71 (s, 3H), 3.13 (d, 
J = 18.8 Hz, 1H), 2.91 (dd, J = 18.8, 1.2 Hz, 1H), 2.54–2.60 (m, 2H), 2.36–2.47 (m, 1H), 
2.08–2.18 (m, 1H), 1.79–1.92 (m, 1H), 1.01 (d, J = 6.9 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ = 215.3, 199.3, 170.3, 60.5, 52.4, 46.1, 40.1, 38.0, 28.6, 15.7; HRMS (ESI) m/z 
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calcd for C10H15O4 [M + H]+: 199.0965, found: 199.0963. 
 
Methyl (1R,2R)-1-(2-(4-hydroxy-2-oxo-2,5-dihydrofuran-3-yl)ethyl)-2-methyl-5-
oxocyclopentane-1-carboxylate (10): A solution containing the aldehyde 9 (0.49 g, 2.47 
mmol, 1.0 eq.), Hantzsch ester  (1.38 g, 5.44 mmol, 2.2 eq.), tetronic acid (0.26 g, 2.47 
mmol, 1.0 eq.) and L-proline (28.5 mg, 0.25 mmol, 0.1 eq.) in methanol (30 mL) was 
stirred for 24 h at rt. After evaporation under reduced pressure, the residue was purified 
by flash chromatography (CH2Cl2/MeOH 20:1) to give ketone 10 (0.56 g, 1.99 mmol, 
81%) as a beige solid; Mp: 125.5–125.9 °C; Rf = 0.23 (CH2Cl2/MeOH 10:1); 𝛼 #%) 
= +12.8 (c 0.27, MeOH); FTIR (neat): ν = 2961, 2942, 2882, 2699, 1746, 1729, 1714, 
1648, 1406, 1231, 1195, 1104, 1041, 988, 767 cm-1; 1H NMR (400 MHz, d4-MeOD) δ = 
4.57 (s, 2H), 3.67 (s, 3H), 2.41–2.52 (m, 2H), 2.23–2.34 (m, 2H), 2.05–2.16 (m, 2H), 
1.85–2.17 (m, 2H), 1.77 (ddd, J = 23.8, 11.5, 8.5 Hz, 1H), 1.05 (d, J = 6.9 Hz, 3H); 13C 
NMR (126 MHz, d4-MeOD) δ = 218.3, 178.4, 175.6, 172.6, 100.8, 68.3, 64.1, 52.2, 40.7, 
39.7, 30.6, 29.3, 17.0, 16.1; elemental analysis calcd for C14H18O6: C = 59.57; H = 6.43; 
found: C = 59.27; H = 6.20; EI-MS 70 eV, m/z (%) = 282.1 (1, M+), 251.1 (9), 157.2 (77), 
141.1 (100), 109.1 (40). 
 
Methyl (1R,2R)-2-methyl-5-oxo-1-(2-(2-oxo-4-(((trifluoromethyl)sulfonyl)oxy)-2,5-
dihydrofuran-3-yl)ethyl)cyclopentane-1-carboxylate (11): Enol 10 (228 mg, 0.81 mmol, 
1.0 eq.) and 2,6-lutidine (95 µl, 0.81 mmol, 1.0 eq.) were dissolved in dry CH2Cl2 (10 
mL) and cooled down to –78 °C. Trifluoromethanesulfonic anhydride (0.14 mL, 
0.81 mmol, 1.0 eq.) was added dropwise in 20 minutes. The reaction mixture was allowed 
to warm up to rt over 7 h. The yellow solution was treated with pentane (10 mL), filtered 
and the filtrate was extracted with EtOAc, washed with saturated NaHCO3 solution and 
brine. The organic layers were dried over Na2SO4, filtered and evaporated. Purification by 
flash chromatography (EtOAc/pentane 1:4) gave vinyltriflate 11 (334 mg, 0.81 mmol, 
quant.) as a slightly yellow solid; Mp: 43.6–44.4 °C; Rf = 0.33 (EtOAc/pentane 1:4); 𝛼 #%&	= +7.2 (c 0.28, MeOH); FTIR (neat): ν = 2962, 2885, 2361, 2340, 1778, 1750, 
1731, 1703, 1434, 1221, 1136, 1087, 1046, 816 cm-1; 1H NMR (400 MHz, CDCl3) δ = 
4.90–4.92 (m, 2H), 3.71 (s, 3H), 2.72–2.52 (m, 2H), 2.41–2.20 (m, 3H), 2.01–2.14 (m, 
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2H), 1.73–1.95 (m, 2H), 1.07 (d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 215.7, 
170.5, 169.8, 160.5, 120.3, 66.6, 62.2, 52.1, 41.2, 38.6, 29.4, 28.3, 17.8, 16.0; 19F NMR 
(376 MHz, CDCl3) δ = –72.81; elemental analysis calcd for C15H17F3O8S: C = 43.48; 
H = 4.14; found: C = 43.60; H = 3.95; EI-MS 70 eV, m/z (%) = 281.1 (16), 249.1 (52), 
221.1 (57), 166.2 (62), 141.1 (100), 109.1 (68).  
 
Methyl (5aR,6R,8aR)-8a-hydroxy-6-methyl-3-oxo-1,3,4,5,6,7,8,8a-octahydro-5aH-
indeno[4,5-c]furan-5a-carboxylate (12): Nickel(II) chloride (106 mg, 0.82 mmol, 0.1 
eq.), chromium(II) chloride (3.12 g, 7.72 mmol, 6.0 eq.) and some 3Å molecular sieves 
were dried in a round bottom flask under reduced pressure with a heat gun. Triflate 11 
(1.70 g, 4.11 mmol, 1.0 eq.) dissolved in dry DMF (40 mL) was degassed and 
subsequently added to the dried chromium- and nickel-mixture. The green mixture was 
stirred at 50 °C for 24 h, then quenched by water (100 mL) and extracted with Et2O until 
no more product could be detected in the aqueous layer by TLC. The combined organic 
layers were dried over Na2SO4, filtered and evaporated. The residue was purified by flash 
chromatography (EtOAc/pentane 1:4) to afford the cyclized product 12 (749.0 mg, 2.81 
mmol, 69%) as a white solid; Mp: 129.5–129.7 °C; Rf = 0.30 (EtOAc/pentane 1:3); 𝛼 #%)	= –37.0 (c 0.26, MeOH); FTIR (neat): ν = 3346, 2956, 2899, 2360, 1728, 1675, 
1443, 1245, 1194, 1153, 1100, 1058, 1015, 653 cm-1; 1H NMR (400 MHz, CDCl3) δ = 
5.06 (d, J = 1.9 Hz, 1H), 4.96–5.03 (m, 1H), 4.78 (dt, J = 17.5, 2.8 Hz, 1H), 3.77 (s, 3H), 
2.25–2.36 (m, 2H), 2.01–2.24 (m, 4H), 1.85–1.95 (m, 2H), 1.73–1.83 (m, 1H), 1.11 (d, J 
= 6.8 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ = 176.5, 173.4, 164.7, 124.8, 80.9, 64.9, 
60.2, 52.4, 41.7, 38.5, 32.9, 31.2, 20.4, 18.7; elemental analysis calcd for C14H18O5: C = 
63.15; H = 6.81; found: C = 63.02; H = 6.80; EI-MS 70 eV, m/z (%) = 266.1 (45, M+), 
238.1 (31), 206.1 (82), 178.1 (100), 133.1 (39), 91.1 (26); X-ray crystal structure is given 
in the supporting information. 
 
(5aR,6R,8aR)-8a-Hydroxy-6-methyl-3-oxo-1,3,4,5,6,7,8,8a-octahydro-5aH-indeno[4,5-
c]furan-5a-carbaldehyde (13): Borane dimethyl sulfide complex (2 M in THF, 0.83 mL, 
1.65 mmol, 2.0 eq.) was added dropwise to a solution of the methylester 12 (220 mg, 0.83 
mmol, 1.0 eq.) in dry THF (4 mL) at 0 °C. The colorless solution was stirred 
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subsequently for 0.5 h and then warmed up to 45 °C for 2 h. After cooling down to rt, 
ethanol was added until the exothermic reaction and gas evolution ceased. After 
evaporation, the residue was purified by flash chromatography (Et2O/pentane 3:1) giving 
aldehyde 13 (149 mg, 0.63 mmol, 76%) as a white solid; Mp: 158.1–158.5 °C; Rf = 0.21 
(Et2O/pentane 3:1); 𝛼 #%& = –49.3 (c 0.23, MeOH); FTIR (neat): ν = 3346, 2942, 2874, 
2758, 1744, 1716, 1669, 1435, 1353, 1224, 1107, 1061, 1016, 929, 753 cm-1; 1H NMR 
(400 MHz, CDCl3) δ = 9.70 (s, 1H), 5.01 (ddd, J = 17.4, 3.4, 1.7 Hz, 1H), 4.80 (dt, J = 
17.4, 2.7 Hz, 1H), 4.07 (d, J = 1.7 Hz, 1H), 2.04–2.36 (m, 6H), 1.72–1.99 (m, 3H), 1.17 
(d, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ = 206.8, 173.1, 163.5, 125.2, 80.1, 
69.5, 61.9, 40.3, 37.7, 31.6, 28.6, 18.8, 17.7; elemental analysis calcd for C13H16O4: C = 
66.09; H = 6.83; found: C = 65.90; H = 6.75; EI-MS 70 eV, m/z (%) = 236.1 (13, M+), 
190.1 (100), 175.1 (66), 145.1 (42), 91.1 (27).  
 
(5aS,6R,8aR,11S)-11-Hydroxy-6-methyl-4,5,7,8-tetrahydro-6H-8a,5a-
(epoxyethano)indeno[4,5-c]furan-3,10(1H)-dione (14): To the aldehyde 13 (43.0 mg, 
0.18 mmol, 1.0 eq.), dissolved in THF/water (1:1, 5 mL), was added potassium cyanide 
(42.0 mg, 0.64 mmol, 3.5 eq.). The resulting mixture was stirred for 2 d at rt before the 
aqueous reaction mixture was extracted several times with EtOAc until no more product 
could be detected in the organic layer by TLC. The combined organic layers were dried 
over Na2SO4, filtered and evaporated. The crude product was purified by flash 
chromatography (EtOAc/cyclohexane 1:1) giving tetracyclic compound 14 (31.0 mg, 
0.12 mmol, 65%) as a white solid; Mp: 194.0–194.3 °C; Rf = 0.28 (EtOAc/cyclohexane 
1:1); 𝛼 #%)= –32.6 (c 0.19, MeOH); FTIR (neat): ν = 3479, 2953, 2929, 2874, 2361, 
1785, 1725, 1682, 1442, 1359, 1217, 1191, 1133, 1086, 1046, 1022, 967 cm-1; 1H NMR 
(400 MHz, CDCl3) δ = 4.82–4.99 (m, 2H), 4.57 (d, J = 2.8 Hz, 1H), 2.91 (d, J = 3.2 Hz, 
1H), 2.45–2.54 (m, 2H), 2.21–2.30 (m, 1H), 2.00–2.10 (m, 3H), 1.83–1.98 (m, 2H), 1.62–
1.70 (m, 1H), 1.42–1.53 (m, 1H), 1.16 (d, J = 6.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) 
δ = 176.3, 172.5, 157.5, 127.8, 87.4, 69.6, 68.9, 56.2, 36.2, 35.9, 30.7, 21.3, 15.8, 14.0; 
HRMS (ESI) m/z calcd for C14H17O5 [M + H]+: 265.1071, found: 265.1065; X-ray crystal 
structure is given in the supporting information. 
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Methyl (5aR,6R)-6-methyl-3-oxo-1,3,4,5,6,7-hexahydro-5aH-indeno[4,5-c]furan-5a-
carboxylate (15): Ester 12 (301 mg, 1.13 mmol, 1.0 eq.) was dissolved in dry THF (16.0 
mL) and Burgess reagent (417 mg, 1.70 mmol, 1.5 eq.) was added. The clear solution was 
stirred for 3.5 h at rt. Water (8.0 mL) was added and the aqueous layer extracted with 
Et2O (3 x 25.0 mL). The combined organic layers were washed with brine (13.0 mL) and 
then dried over Na2SO4, filtered and evaporated to obtain a white solid. The residue was 
purified by flash chromatography (pentane/EtOAc 3:1) to obtain the desired olefin 15 
(262 mg, 1.06 mmol, 93%) as a white solid; Mp: 124.9–125.6 °C; Rf = 0.24 
(pentane/EtOAc 4:1); 𝛼 #%)	= +193.5 (c 0.16, CHCl3); FTIR (neat) ν = 2952, 2936, 2846, 
1740, 1715, 1644, 1439, 1346, 1239, 1172, 1042, 1014, 980, 761, 744 cm-1; 1H NMR 
(400 MHz, CDCl3) δ = 6.18 (s, 1H), 4.98–4.81 (m, 2H), 3.67 (s, 3H), 2.74–2.56 (m, 1H), 
2.52–2.15 (m, 2H), 1.35 (ddd, J = 12.8, 11.7, 5.8 Hz, 1H), 1.07 (d, J = 7.0 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ = 173.8, 173.1, 151.8, 136.2, 133.2, 126.5, 69.1, 59.9, 
52.0, 45.8, 40.6, 30.8, 19.7, 14.9; HRMS (ESI) m/z calcd for C14H17O4 [M + H]+: 
249.1121, found: 249.1119; X-ray crystal structure is given in the supporting information. 
 
Methyl (5aR,6R,8R,8aS)-8,8a-dihydroxy-6-methyl-3-oxo-1,3,4,5,6,7,8,8a-octahydro-5aH-
indeno[4,5-c]furan-5a-carboxylate (16): Olefin 15 (80.0 mg, 0.32 mmol, 1.0 eq.) and 
NMO (49.7 mg, 0.48 mmol, 1.5 eq.) were dissolved in tert-butanol (3 mL) and water (1 
mL). The clear solution was cooled to 0° C and OsO4 (4% solution in water, 0.13 mL, 
16.1 μmol, 5 mol%) was added dropwise. The clear solution was then allowed to warm 
up to rt and then stirred for 3 days. To the yellow solution was added saturated Na2SO3 
solution (15 mL) and the orange to yellow emulsion was stirred for 30 minutes at rt. The 
mixture was extracted with EtOAc (3 x 10 mL) and the combined organic layers were 
washed with brine (10 mL), dried over Na2SO4, filtered and evaporated to obtain a yellow 
oil. The crude was purified by flash chromatography (pentane/EtOAc 1:1) to obtain the 
desired diol 16 (76.7 mg, 0.27 mmol, 84%, dr = 10:1) as a white solid; Mp: 126.3–126.8 
°C; Rf = 0.25 (pentane/EtOAc 1:1); 𝛼 #%)	= +45.6 (c 0.16, CHCl3); FTIR (neat) ν = 3449, 
2959, 2929, 2360, 1727, 1714, 1660, 1429, 1351, 1255, 1202, 1037, 1021, 739 cm-1; 1H 
NMR (400 MHz, CDCl3) δ = 5.16 (dd, J = 12.2, 6.4 Hz, 1H), 5.03–4.70 (m, 2H), 3.69 (s, 
1H), 3.62 (s, 3H), 2.72–2.53 (m, 1H), 2.50–2.40 (m, 1H), 2.40–2.22 (m, 3H), 2.22–2.09 
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(m, 1H), 1.90 (dd, J = 9.2, 7.0 Hz, 2H), 0.90 (d, J = 7.1 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ = 173.9, 173.5, 162.6, 128.0, 76.9, 71.5, 69.1, 63.3, 51.7, 41.4, 37.5, 22.4, 19.8, 
15.7; HRMS (ESI) m/z calcd for C14H19O6 [M + H]+: 283.1176, found: 283.1178. 
 
Methyl (3aR,5aR,6R,8R,8aS,8bS)-8,8a-dihydroxy-6-methyl-3-oxodecahydro-5aH-
indeno[4,5-c]furan-5a-carboxylate (17): Diol 16 (12.5 mg, 44.3 μmol, 1.0 eq.) and 
Rh/C/Al2O3 (5% Rh, 9.1 mg, 4.43 μmol, 0.1 eq.) were dissolved in dry EtOAc (0.3 mL) 
and hydrogenated at rt under a 60 bar H2 pressure. After 3 h, the reaction was filtered over 
celite and vigorously washed with EtOAc. The solvent was evaporated under reduced 
pressure to obtain a white solid. The residue was purified by flash chromatography 
(pentane/EtOAc 1:1) to obtain the desired hydrogenated lactone 17 (12.6 mg, 44.3 μmol, 
quant.) as a white solid; Mp: 197.7–198.5 °C; Rf = 0.31 (EtOAc/pentane 1:1); 𝛼 #%)	= –
110.8 (c 0.12, CHCl3); FTIR (neat) ν = 3498, 3425, 2955, 2871, 1743, 1708, 1366, 1202, 
1038, 974, 716, 617 cm-1; 1H NMR (500 MHz, CDCl3) δ = 4.91 (dd, J = 9.2, 4.1 Hz, 1H), 
4.24 (dd, J = 9.7, 8.3 Hz, 1H), 4.00 (dd, J = 11.5, 9.7 Hz, 1H), 3.69 (s, 3H), 3.43 (s, 1H), 
2.93–2.84 (m, 2H), 2.63–2.55 (m, 1H), 2.22 (dt, J = 13.0, 3.6 Hz, 1H), 2.10 (brs, 1H), 
2.06 (ddd, J = 10.6, 6.6, 3.5 Hz, 1H), 1.93–1.75 (m, 3H), 1.56–1.47 (m, 1H), 0.77 (d, J = 
7.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ = 179.2, 174.3, 80.0, 72.5, 67.4, 59.6, 51.7, 
44.1, 39.9, 39.3, 38.2, 24.9, 22.1, 14.7; HRMS (ESI) m/z calcd for C14H21O6 [M + H]+: 
285.1333, found: 285.1334; X-ray crystal structure is given in the supporting information. 
 
Methyl (3aS,5R,7aR)-1,4-dioxo-5-((R)-4-oxobutan-2-yl)octahydroisobenzofuran-5-
carboxylate (18): Diol 17 (11.3 mg, 39.7 μmol, 1.0 eq.) was dissolved in THF/water (2:1, 
0.47 mL) and NaIO4 (27.8 mg, 0.13 mmol, 3.2 eq.) was added at rt. After 1.5 h, the 
reaction mixture was diluted with EtOAc (2 mL) and filtered over Na2SO4. The filtrate 
was vigorously washed with EtOAc (4 x 2 mL). The solvent was evaporated to obtain a 
white solid. The residue was purified by flash chromatography (pentane/EtOAc 2:1) to 
obtain the desired ketoaldehyde 18 (12.5 mg, 43.6 μmol, quant.) as colorless oil; Rf = 
0.38 (EtOAc/pentane 1:1); 𝛼 #%)	= –137.3 (c 0.12, CHCl3); FTIR (neat) ν = 2955, 1770, 
1712, 1452, 1167, 998, 732, 626 cm-1; 1H NMR (400 MHz, CDCl3) δ = 9.71 (s, 1H), 4.86 
(dd, J = 9.4, 1.9 Hz, 1H), 4.19 (dd, J = 9.4, 6.6 Hz, 1H), 3.70 (s, 3H), 3.30–3.18 (m, 2H), 
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2.93–2.84 (m, 1H), 2.82–2.68 (m, 2H), 2.29–2.17 (m, 2H), 2.15–2.04 (m, 2H), 1.07 (d, J 
= 6.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 205.4, 201.3, 176.7, 170.7, 66.2, 63.0, 
52.5, 47.5, 45.6, 40.2, 29.1, 28.8, 18.8, 15.8. 
 
Methyl (3aS,5R,7aR)-5-((R)-1-(1,3-dioxolan-2-yl)propan-2-yl)-1,4-dioxo-
octahydroisobenzofuran-5-carboxylate (19): To the diol 17 (130.0 mg, 0.45 mmol, 1.0 
eq.) dissolved in a THF and water mixture (3:1, 5 mL) was added sodium periodate 
(332.0 mg, 1.60 mmol, 3.4 eq.). The mixture was stirred at rt for 2 h and subsequently 
dried by filtrating the mixture through a patch of Na2SO4 and washed with EtOAc. The 
solvent was evaporated, and the residue was obtained as colorless oil. The crude 
ketoaldehyde 18 was dissolved in dry benzene (4 mL), and ethylene glycol (27 μL, 0.48 
mmol, 1.1 eq.) was added, followed by p-TSA (9.2 mg, 0.05 mmol, 0.1 eq.). The 
resulting solution was heated to reflux (90 °C). After 1 h 45 min, the solution was 
allowed to cool to rt, and was then treated with saturated NaHCO3 solution (3 mL) 
followed by extraction with EtOAc three times. The combined organic layers were 
washed with water, dried over Na2SO4 and evaporated under reduced pressure. The 
residue was subjected to flash chromatography on silica (CH2Cl2/MeOH, 20:1) and 
concentrated to give protected aldehyde 19 (149.0 mg, 0.45 mmol, quant.) as a white 
solid; Rf = 0.63 (CH2Cl2/MeOH 20:1); 𝛼 #%) = –75.5 (c 0.77, CHCl3); FTIR (neat) ν = 
2954, 2887, 1773, 1737, 1709, 1450, 1372, 1343, 1297, 1220, 1188, 1148, 1121, 1050, 
1027, 998, 962, 734 cm-1; 1H NMR (500 MHz, CDCl3) δ = 4.95 (dd, J = 9.3, 1.8 Hz, 1H), 
4.86 (dd, J = 6.4, 2.6 Hz, 1H), 4.14 (dd, J = 9.3, 6.5 Hz, 1H), 3.97–3.90 (m, 2H), 3.87–
3.79 (m, 2H), 3.70 (s, 3H), 3.47 (ddd, J = 10.0, 6.4, 1.7 Hz, 1H), 3.18 (ddd, J = 10.1, 6.4, 
5.1 Hz, 1H), 2.42–2.35 (m, 1H), 2.22–2.07 (m, 4H), 2.03 (ddd, J = 14.9, 9.8, 2.6 Hz, 1H), 
1.54 (ddd, J = 14.9, 6.4, 0.8 Hz, 1H), 1.09 (d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ = 205.2, 176.8, 170.9, 103.3, 66.0, 65.1, 64.9, 64.2, 52.2, 45.7, 40.9, 36.8, 30.3, 
29.1, 18.6, 15.4; HRMS (ESI) m/z calcd for C16H23O7 [M + H]+: 327.1438, found: 
327.1443. 
 
Methyl (3aR,5R,7aR)-5-((R)-1-(1,3-dioxolan-2-yl)propan-2-yl)-3a-(hydroxymethyl)-1,4-
dioxooctahydroisobenzofuran-5-carboxylate (20): Acetal 19 (161.0 mg, 0.49 mmol, 1.0 
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eq.) was dissolved in THF (2.8 mL), and formaline (37% aq. solution, 8.3 mL, 112 mmol, 
226 eq.) was added, followed by aq. citrate buffer solution (8.3 mL, pH 6.0). The 
resulting solution was heated to 40 °C and stirred overnight. After cooling to rt, the 
reaction mixture was diluted with EtOAc and water. The aqueous layer was extracted 
three times with EtOAc, and the combined organic layers were washed with water, dried 
over Na2SO4, and evaporated under reduced pressure. The crude residue was dissolved in 
a CH2Cl2/MeOH mixture (20:1) and filtered through a pad of silica. Purification by flash 
chromatography (CH2Cl2/MeOH 20:1) gave alcohol 20 (164.3 mg, 0.46 mmol, 94%) as a 
white solid; Rf = 0.30 (CH2Cl2/MeOH 20:1); 𝛼 #%)	= –23.5 (c 0.30, CHCl3); FTIR (neat): ν = 3467, 2957, 2923, 2854, 1766, 1728, 1702, 1465, 1437, 1382, 1300, 1223, 1174, 
1137, 1096, 1017, 952, 881, 860, 826, 751, 713 cm-1; 1H NMR (400 MHz, CDCl3) δ = 
4.87 (dd, J = 5.8, 3.5 Hz, 1H), 4.34 (d, J = 9.8 Hz, 1H), 4.13 (d, J = 9.8 Hz, 1H), 4.00–
3.91 (m, 3H), 3.88–3.79 (m, 2H), 3.71 (s, 3H), 3.60 (d, J = 10.8 Hz, 1H), 3.02–2.93 (m, 
1H), 2.38–2.19 (m, 3H), 2.05 (ddd, J = 12.9, 11.5, 2.3 Hz, 1H), 1.98–1.84 (m, 1H), 1.79–
1.64 (m, 2H), 1.12 (d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 208.5, 177.5, 
171.4, 103.7, 70.9, 67.0, 65.0, 64.8, 63.3, 56.6, 42.8, 35.8, 33.8, 30.5, 28.9, 20.8, 17.0; 
HRMS (ESI) m/z calcd for C17H25O8 [M + H]+: 357.1544, found: 357.1552. 
 
Methyl (3aR,5R,7aR)-5-((R)-1-(1,3-dioxolan-2-yl)propan-2-yl)-3a (iodomethyl)-1,4-
dioxooctahydroisobenzofuran-5-carboxylate (21): Alcohol 20 (408 mg, 1.14 mmol, 1.0 
eq.), triphenylphosphine (600 mg, 2.29 mmol, 2.0 eq.) and imidazole (311 mg, 4.57 
mmol, 4.0 eq.) were dissolved in dry benzene (30 mL) under argon atmosphere. Iodine 
(580 mg, 2.29 mmol, 2.0 eq.) was added at rt and the resulting mixture was stirred for 12 
hours at that temperature. The reaction was quenched with a 1:1 mixture of saturated 
NaHCO3 and Na2S2O3 solution and extracted three times with EtOAc. The combined 
organic layers were dried over Na2SO4, filtered and evaporated under reduced pressure. 
The residue was purified by flash chromatography on silica (pentane/EtOAc 5:2) giving 
iodide 21 (401.2 mg, 0.86 mmol, 75%) as colorless oil; Rf = 0.23 (pentane/EtOAc 3:1); 𝛼 #%)	= +17.9 (c 0.48, CHCl3); FTIR (neat): ν = 2954, 2886, 2360, 1781, 1731, 1710, 
1436, 1366, 1225, 1162, 1030, 947, 824, 732 cm-1; 1H NMR (400 MHz, CDCl3) δ = 4.87 
(dd, J = 5.8, 3.7 Hz, 1H), 4.39 (d, J = 10.2 Hz, 1H), 4.01 (d, J = 10.2 Hz, 1H), 3.98–3.87 
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(m, 3H), 3.86–3.78 (m, 2H), 3.72 (s, 3H), 3.15 (d, J = 10.3 Hz, 1H), 3.14–3.08 (m, 1H), 
2.49–2.38 (m, 1H), 2.33–2.24 (m, 2H), 2.08–1.98 (m, 1H), 1.86 (tdd, J = 13.3, 8.3, 2.3 
Hz, 1H), 1.72–1.55 (m, 2H), 1.11 (d, J = 6.8 Hz, 3H) ; 13C NMR (126 MHz, CDCl3) δ = 
203.7, 176.2, 171.1, 103.5, 72.9, 65.1, 64.8, 63.5, 55.3, 53.0, 46.9, 36.4, 35.6, 27.5, 20.8, 
17.4, 11.3; HRMS (ESI) m/z calcd for C17H24IO7 [M + H]+: 467.0561, found: 467.0557. 
 
Methyl (3aS,5R,7aR)-5-((R)-1-(1,3-dioxolan-2-yl)propan-2-yl)-3a-methyl-1,4-
dioxooctahydroisobenzofuran-5-carboxylate (22): Iodide 21 (401.0 mg, 0.86 mmol, 1.0 
eq.) was dissolved in dry and degassed benzene (30 mL) under argon atmosphere. 
Tri-n-butyltin hydride (348 µL, 1.29 mmol, 1.5 eq.) and AIBN (42.0 mg, 0.26 mmol, 0.3 
eq.) were added and the mixture was stirred for 3 h at 85 °C. The solvent was removed in 
vacuo and the residue was purified by flash column chromatography (pentane/EtOAc 2:1) 
to give the ketone 22 (242.0 mg, 0.72 mmol, 84%) as colorless oil. Rf = 0.18 
(pentane/EtOAc 2:1); 𝛼 #%)	= –68.5 (c 0.49, MeOH); FTIR (neat) ν = 2955, 2887, 1776, 
1733, 1709, 1457, 1364, 1297, 1230, 1148, 1020, 963, 823, 733 cm-1; 1H NMR (400 
MHz, CDCl3) δ = 4.85 (t, J = 4.8 Hz, 1H), 4.47 (d, J = 9.3 Hz, 1H), 3.95–3.84 (m, 3H), 
3.83–3.75 (m, 2H), 3.64 (s, 3H), 2.61 (dd, J = 10.3, 6.1 Hz, 1H), 2.43–2.32 (m, 1H), 
2.26–2.11 (m, 2H), 2.03–1.86 (m, 2H), 1.59–1.53 (m, 2H), 1.33 (s, 3H), 1.03 (d, J = 6.8 
Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 207.7, 177.5, 171.1, 103.5, 74.6, 65.0, 64.7, 
63.3, 52.6, 50.9, 46.3, 36.1, 34.8, 27.7, 24.3, 19.5, 16.8; HRMS (ESI) m/z calcd for 
C17H25O7 [M + H]+: 341.1595, found: 341.1591. 
 
Methyl (3aS,5R,7aR)-3a-methyl-1,4-dioxo-5-((R)-4-oxobutan-2-
yl)octahydroisobenzofuran-5-carboxylate (23): The ketone 22 (227.0 mg, 0.67 mmol, 1.0 
eq.) was dissolved in acetone (10 mL) and 1 M aq. HCl solution (5 mL) was added. The 
resulting mixture was stirred at rt for 17 h. The reaction was quenched by addition of a 
saturated aq. NaHCO3 solution and extracted three times with EtOAc. The combined 
organic layers were dried over Na2SO4, filtered and evaporated under reduced pressure to 
yield pure aldehyde 23 (195.8 mg, 0.66 mmol, 99%) as colorless oil; Rf = 0.56 
(pentane/EtOAc 1:1); 𝛼 #%)	= –87.8 (c 0.42, CHCl3); FTIR (neat): ν = 2956, 2360, 2339, 
1776, 1717, 1457, 1385, 1295, 1234, 1155, 1022, 991, 787 cm-1; 1H NMR (400 MHz, 
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CDCl3) δ = 9.72 (d, J = 1.7 Hz, 1H), 4.60 (d, J = 9.4 Hz, 1H), 3.90 (d, J = 9.4 Hz, 1H), 
3.68 (s, 3H), 2.94 (dqd, J = 9.8, 6.8, 3.0 Hz, 1H), 2.69 (t, J = 7.4 Hz, 1H), 2.67–2.60 (m, 
1H), 2.52–2.43 (m, 1H), 2.31–2.19 (m, 2H), 2.08–1.94 (m, 2H), 1.36 (s, 3H), 1.00 (d, J = 
6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 208.1, 200.7, 177.3, 170.8, 74.7, 62.3, 
52.8, 51.2, 46.8, 46.2, 31.3, 27.2, 24.5, 18.9, 16.6; HRMS (ESI) m/z calcd for C15H21O6 
[M + H]+: 297.1333 found: 297.1328. 
 
Methyl (3aS,5R,7aR)-5-((R)-4-hydroxybutan-2-yl)-3a-methyl-1,4-
dioxooctahydroisobenzofuran-5-carboxylate (24): Aldehyde 23 (78.1 mg, 0.26 mmol, 1.0 
eq.) was dissolved in hexafluoroisopropanol (1 mL). Sodium 
tris(hexafluoroisoproopoxy)borohydride  (1 M in THF, 791 µL, 0.79 mmol, 3.0 eq.) was 
added at rt under nitrogen atmosphere and stirred for 15 h. The reaction was quenched by 
addition of saturated NH4Cl solution and extracted three times with EtOAc. The 
combined organic layers were dried over Na2SO4, filtered and evaporated under reduced 
pressure. The residue was purified by flash chromatography (pentane/EtOAc 2:3) giving 
alcohol 24 (66.9 mg, 0.224 mmol, 85%) as colorless oil; Rf = 0.26 (EtOAc/pentane 3:2); 𝛼 #%)	= –79.9 (c 0.18, MeOH); FTIR (neat): ν = 3529, 3407, 2955, 2884, 1775, 1731, 
1708, 1456, 1385, 1364, 1293, 1231, 1187, 1154, 1055, 1021, 989, 916, 848, 732, 681 
cm-1; 1H NMR (400 MHz, CDCl3) δ = 4.48 (d, J = 9.3 Hz, 1H), 3.94 (d, J = 9.3 Hz, 1H), 
3.74 (ddd, J = 11.0, 8.8, 5.5 Hz, 1H), 3.69 (s, 3H), 3.67–3.58 (m, 1H), 2.64 (t, J = 8.4 Hz, 
1H), 2.45–2.34 (m, 1H), 2.28 (dt, J = 9.3, 4.4 Hz, 1H), 2.25–2.17 (m, 1H), 2.07–1.92 (m, 
2H), 1.69–1.52 (m, 2H), 1.39–1.33 (m, 1H), 1.37 (d, J = 2.9 Hz, 3H), 0.99 (d, J = 6.8 Hz, 
3H); 13C NMR (101 MHz, CDCl3) δ = 208.1, 177.5, 171.3, 74.6, 63.2, 61.0, 52.8, 51.0, 
46.5, 35.3, 34.8, 27.4, 24.4, 19.8, 16.1; HRMS (ESI) m/z calcd for C15H22NaO6 [M + 
Na]+: 321.1309, found: 321.1308. 
 
 
Methyl (3aS,5R,7aR)-5-((R)-4-iodobutan-2-yl)-3a-methyl-1,4-
dioxooctahydroisobenzofuran-5-carboxylate (25): Alcohol 24 (26.0 mg, 0.087 mmol, 1.0 
eq.) was dissolved in dry benzene (5 mL) under nitrogen atmosphere. 
Triphenylphosphine (45.7 mg, 0.174 mmol, 2.0 eq.), imidazole (23.7 mg, 0.349 mmol, 
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4.0 eq.), and iodine (44.2 mg, 0.174 mmol, 2.0 eq.) were added at rt and the resulting 
mixture was stirred overnight. The crude mixture was filtered, washed with benzene and 
evaporated under reduced pressure. The resulting oil was purified by flash 
chromatography (pentane/EtOAc 2:1) to give iodide 25 (33.8 mg, 0.083 mmol, 95%) as a 
white solid; Rf = 0.44 (pentane/EtOAc 2:1); 𝛼 #%) = –9.8 (c 0.58, CHCl3); FTIR (neat): ν 
= 3245, 2971, 2927, 2860, 2171, 1762, 1728, 1700, 1591, 1532, 1489, 1439, 1385, 1368, 
1287, 1230, 1207, 1173, 1119, 1069, 1012, 977, 961, 922, 905, 852, 773, 764, 722, 692 
cm-1; 1H NMR (400 MHz, CDCl3) δ = 4.48 (d, J = 9.3 Hz, 1H), 3.93 (d, J = 9.3 Hz, 1H), 
3.71 (s, 3H), 3.33 (ddd, J = 9.8, 7.7, 4.3 Hz, 1H), 3.07 (td, J = 9.5, 7.1 Hz, 1H), 2.68–2.60 
(m, 1H), 2.37–2.14 (m, 3H), 2.05–1.91 (m, 2H), 1.89–1.78 (m, 1H), 1.71–1.60 (m, 1H), 
1.37 (s, 3H), 0.97 (d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 207.7, 177.4, 
171.0, 74.6, 63.1, 52.9, 51.0, 46.4, 39.5, 35.6, 27.6, 24.5, 19.7, 15.1, 4.4; HRMS (ESI) 
m/z calcd for C15H22IO5 [M + H]+: 409.0506, found: 409.0508; X-ray crystal structure is 
given in the supporting information. 
 
Samarium(II) iodide: Following a literature procedure, 48 samarium (151 mg, 1.0 mmol, 
1.0 eq.) was activated by hot stirring with a heat gun in vacuo. After cooling, 1,2-
diiodoethane (prewashed by extraction with saturated aqueous Na2S2O3 solution, 141 mg, 
0.5 mmol, 1.0 eq.) was added under argon atmosphere. THF (dried over sodium, 2 mL) 
was added and the mixture was stirred for 5 min at room temperature. After that time, 
more THF (3 mL) was added and the solution was stirred until it turned dark blue and 
SmI2 was obtained as a 0.1 M solution in THF and was used as such. 
 
Methyl (3aR,5aR,6R,8aR,8bS)-8a-hydroxy-6,8b-dimethyl-3-oxodecahydro-5aH-
indeno[4,5-c]furan-5a-carboxylate (26): Iodide 25 (118.0 mg, 0.289 mmol, 1.0 eq.) was 
dissolved in hexamethylphosphoramide (500 µL, 2.89 mmol, 10.0 eq.) under nitrogen 
atmosphere and cooled down to 0 °C. A freshly prepared SmI2 solution (0.1 M in THF, 
7.22 mL, 0.722 mmol, 2.5 eq.) was added and the resulting mixture was slowly heated up 
to rt and stirred for 1 hour. The reaction was quenched by addition of a saturated aqueous 
Rochelle's salt solution and stirred at that temperature for 20 min. Extraction was 
performed three times with EtOAc. The combined organic layers were dried over 
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Na2SO4, filtered and evaporated under reduced pressure. The residue was purified by 
flash chromatography on silica (pentane/EtOAc 4:1, CAM dip) giving the tricyclic 
product 26 (61.5 mg, 0.218 mmol, 76%) as a white solid; Mp: 97.8–98.6 °C; Rf = 0.41 
(pentane/EtOAc 4:1); 𝛼 #%)	= –17.6 (c 0.29, MeOH); FTIR (neat): ν = 3495, 2959, 2900, 
2877, 1770, 1708, 1454, 1435, 1384, 1354, 1325, 1291, 1270, 1239, 1181, 1148, 1102, 
1076, 1058, 1040, 1009, 988, 966, 920, 896, 845, 768, 739, 714, 681 cm-1; 1H NMR (400 
MHz, CDCl3) δ = 5.17 (d, J = 2.1 Hz, 1H), 4.44 (d, J = 9.5 Hz, 1H), 3.97 (d, J = 9.5 Hz, 
1H), 3.79 (s, 3H), 2.40–2.32 (m, 1H), 2.24–2.16 (m, 1H), 2.14–2.00 (m, 2H), 1.96–1.86 
(m, 2H), 1.82–1.71 (m, 1H), 1.66–1.58 (m, 1H), 1.43 (td, J = 13.9, 2.6 Hz, 1H), 1.35–
1.29 (m, 1H), 1.23 (s, 3H), 1.00 (d, J = 6.9 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ = 
178.8, 178.5, 85.4, 74.6, 58.0, 52.6, 48.1, 46.8, 45.1, 36.9, 33.8, 29.4, 23.1, 22.4, 21.2; 
HRMS (ESI) m/z calcd for C15H22NaO5 [M + Na]+: 305.1359, found: 305.1359. 
 
(3aR,5aR,6R,8aR,8bS)-8a-Hydroxy-6,8b-dimethyl-3-oxodecahydro-5aH-indeno[4,5-
c]furan-5a-carbaldehyde (27): In a dry round bottomed flask under argon atmosphere, 
ester 26 (19.7 mg, 0.070 mmol, 1.0 eq.) was dissolved in dry THF (2 mL) and cooled to 0 
°C. Borane-methyl sulfide complex (2 M in THF, 70 µL, 0.140 mmol, 2.0 eq.) was 
added, the resulting mixture was stirred for 15 min at 0 °C and subsequently at 45 °C for 
5.5 h. The mixture was allowed to cool down to rt for 10 min before ethanol was added 
until bubbling (exothermic) ceased. The solution was evaporated giving a colorless oil. 
Purification was performed by flash chromatography (pentane/EtOAc 3:2) giving 
aldehyde 27 (11.6 mg, 0.0460 mmol, 66%) as a white solid; Mp: 51.4–51.9 °C; Rf = 0.32 
(pentane/EtOAc 3:2, CAM dip); 𝛼 #%)	= –13.7 (c 0.19, MeOH); FTIR (neat) ν = 3484, 
2957, 2876, 1748, 1704, 1460, 1373, 1287, 1227, 1158, 1140, 1003, 973, 855, 793, 732, 
690, 551 cm-1; 1H NMR (400 MHz, CDCl3) δ = 9.84 (s, 1H), 4.23 (d, J = 0.8 Hz, 1H), 
3.95 (d, J = 9.6 Hz, 1H), 3.51 (s, 1H), 2.29–2.18 (m, 2H), 2.12 (dddd, J = 14.4, 10.4, 9.1, 
2.2 Hz, 2H), 1.98–1.84 (m, 2H), 1.82–1.72 (m, 1H), 1.72–1.60 (m, 1H), 1.51–1.41 (m, 
1H), 1.41–1.32 (m, 1H), 1.22 (d, J = 0.8 Hz, 3H), 1.08 (d, J = 7.0 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ = 210.1, 178.9, 86.4, 75.0, 59.8, 47.5, 46.4, 44.6, 37.8, 31.5, 30.5, 22.5, 
22.3, 19.8; HRMS (ESI) m/z calcd for C14H20O4Na [M + Na]+: 275.1254, found: 
275.1253. 
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(3aR,5aS,6R,8aR,8bS,11S)-11-Hydroxy-6,8b-dimethylhexahydro-6H-8a,5a-
(epoxyethano)indeno[4,5-c]furan-3,10(1H)-dione (28): In a dry round bottomed flask 
under argon atmosphere, ester 26 (31.8 mg, 0.113 mmol, 1.0 eq.) was dissolved in dry 
THF (3 mL) and cooled to 0 °C. Borane-methyl sulfide complex (2 M in THF, 113 µL, 
0.225 mmol, 2.0 eq.) was added, the resulting mixture was stirred for 15 min at 0 °C and 
subsequently at 45 °C for 7 h. The mixture was allowed to cool down to rt for 10 min 
before ethanol was added until bubbling (exothermic) ceased. The solution was 
evaporated giving a colorless oil. Crude aldehyde 27 was dissolved in THF/water (1:1, 4 
mL) and potassium cyanide (25.8 mg, 0.396 mmol, 3.5 eq.) was added. The mixture was 
stirred for 2 d before EtOAc was added and the mixture was stirred for an additional day. 
The phases were separated and the aqueous layer was extracted with EtOAc for an 
additional day. Extractions were performed until no more product was observed in the 
separated organic layer. The combined organic layers were dried over Na2SO4, filtered 
and evaporated under reduced pressure. The residue was purified by flash 
chromatography (EtOAc/pentane 3:2) giving lactone 28 (20.0 mg, 0.0713 mmol, 63%) as 
a white solid; Rf = 0.33 (EtOAc/pentane 1:1); 𝛼 #%)	= –41.9 (c 0.16, MeOH); FTIR (neat) ν = 3421, 2965, 2888, 1774, 1758, 1678, 1462, 1379, 1254, 1196, 1159, 1132, 1091, 
1026, 974, 944, 876, 820, 753, 716 cm-1; 1H NMR (400 MHz, CDCl3) δ = 4.40 (d, J = 9.6 
Hz, 1H), 4.35 (d, J = 2.8 Hz, 1H), 3.92 (d, J = 9.6 Hz, 1H), 2.69 (d, J = 2.9 Hz, 1H), 2.47 
(dt, J = 8.3, 4.2 Hz, 1H), 2.29–2.19 (m, 1H), 2.12–2.00 (m, 3H), 1.90–1.78 (m, 2H), 
1.75–1.65 (m, 1H), 1.35 (s, 3H), 1.08 (d, J = 6.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
= 179.7, 176.8, 98.1, 75.7, 68.7, 53.5, 44.7, 44.3, 43.0, 34.5, 30.2, 25.3, 22.3, 20.2, 14.5; 
HRMS (ESI) m/z calcd for C15H21O5 [M + H]+: 281.1384, found: 281.1380. 
 
(3aS,4R,6S,6aS,7R,9aR,9bS)-7,9b-Dimethylhexahydro-3H,6H,7H-9a,6-(epoxymethano)-
4,6a-methanocyclopenta[c]furo[3,4-e]oxepine-3,11-dione (29): Alcohol 28 (2.5 mg, 8.9 
µmol, 1.0 eq.) was dissolved in dry THF (1 mL) under nitrogen atmosphere and cooled 
down to –78 °C. LDA (0.28 M in THF, 96 µL, 26.8 µmol, 3.0 eq.) was added at –78 °C 
and the mixture was stirred for 1 h. A solution of phenylselenyl bromide (4.2 mg, 17.8 
µmol, 2.0 eq.) in THF (0.15 mL) and was then added at –78 °C. The resulting mixture 
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was stirred for 1 h at that temperature and subsequently heated up to 0 °C and stirred for 
additional 30 min. The reaction mixture was diluted with a saturated NH4Cl solution and 
EtOAc. The layers were separated and the aqueous layer was extracted twice with 
EtOAc. The combined organic layers were dried over Na2SO4, filtered and evaporated 
under reduced pressure. The residue was dissolved in THF (1 mL) and cooled down to 0 
°C. One drop of AcOH and H2O2 (35% in water) were added and the mixture was stirred 
for 2 h before a saturated NaHCO3 solution was added and stirred 1 h at rt. Extraction 
was performed three times with EtOAc. The combined organic layers were dried over 
Na2SO4, filtered and evaporated under reduced pressure. Purification was performed by 
flash chromatography to yield the desired product 29 (1.2 mg, 4.31 µmol, 48%) as a 
crystalline solid; Rf = 0.21 (pentane/EtOAc 1:4); 𝛼 #%)	= –68.4 (c 0.29, MeOH); FTIR 
(neat): ν = 3357, 2923, 2853, 1762, 1662, 1467, 1378, 1263, 1208, 1159, 1095, 1022, 
962, 930, 902, 795, 748 cm-1; 1H NMR (400 MHz, d4-MeOD) δ = 4.75 (t, J = 5.7 Hz, 
1H), 4.65 (d, J = 9.3 Hz, 1H), 4.01 (s, 1H), 3.87 (d, J = 9.3 Hz, 1H), 3.07 (d, J = 5.2 Hz, 
1H), 2.31–2.21 (m, 2H), 2.09–1.94 (m, 4H), 1.36 (s, 3H), 1.27–1.15 (m, 1H), 1.08 (d, J = 
7.0 Hz, 3H); 13C NMR (101 MHz, d4-MeOD) δ = 177.7, 174.9, 101.9, 78.7, 75.6, 75.5, 
60.4, 55.4, 44.7, 39.0, 35.4, 34.0, 32.8, 27.3, 15.8; HRMS (ESI) m/z calcd for C15H19O5 
[M + H]+: 279.1227, found: 279.1223; X-ray crystal structure is given in the supporting 
information. 
 
 
Methyl (1R,2R)-1-((R)-5-(benzyloxy)-4-methyl-3-oxopentyl)-2-methyl-5-oxocyclopentane-
1-carboxylate (35): To a solution of β-keto ester 7 (10 mg, 0.064 mmol, 1.0 eq) and 
enone 34 (19.6 mg, 0.096 mmol, 1.2 eq) in acetone (0.25 mL) was added K2CO3 (4.4 mg, 
0.032 mmol, 0.5 eq) and the mixture was heated to 40 °C overnight. After cooling down 
to room temperature the mixture was filtered through a short pad of celite. The solvent 
was removed and the residue was subjected to flash column chromatography 
(pentane/Et2O 5:1 to 3:1) to give ester 35 (16.2 mg, 45 µmol, 70%) as colorless oil; Rf = 
0.53 (pentane/Et2O 6:1); 𝛼 #%* = +27.3 (c 0.44, CHCl3,); FTIR (neat): ν = 2960, 2877, 
2361, 1729, 1496, 1455, 1375, 1236, 1168, 1101, 1026, 997, 741, 699 cm−1; 1H NMR 
(400 MHz, CDCl3) δ = 7.36–7.26 (m, 5H), 4.48 (d, J = 3.2 Hz, 2H), 3.68 (s, 3H), 3.62 
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(dd, J = 9.1, 7.7 Hz, 1H), 3.49–3.44 (m, 1H), 2.91–2.78 (m, 2H), 2.59–2.46 (m, 2H), 
2.24–2.08 (m, 3H), 2.06–1.87 (m, 2H), 1.79–1.66 (m, 1H), 1.07 (d, J = 7.0 Hz, 3H), 1.01 
(d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 216.5, 212.4, 171.0, 138.3, 128.5, 
127.7, 127.7, 73.4, 72.5, 62.0, 51.9, 46.7, 41.6, 38.7, 37.2, 28.3, 26.1, 16.0, 13.7; HRMS 
(ESI) m/z calcd for C21H28NaO5 [M + Na]+: 383.1829, found: 383.1834. 
 
Methyl (1R,2R)-1-((R)-5-hydroxy-4-methyl-3-oxopentyl)-2-methyl-5-oxocyclopentane-1-
carboxylate (36): A mixture of ester 35 (50.0 mg, 0.139 mmol, 1.0 eq) and 5 % Pd/C 
(44.3 mg, 0.021 mmol, 15 mol%) in EtOH (3.0 mL) was stirred under a hydrogen 
atmosphere. After completion of the reaction (2.5 h), the mixture was filtered through a 
short pad of celite and the solvent was removed under reduced pressure to give alcohol 36 
(37.5 mg, 0.139 mmol, quant.) as colorless oil; Rf = 0.16 (pentane/Et2O 1:2); 𝛼 #%& = 
+40.0 (c 0.98, CHCl3); FTIR (neat): ν = 3732, 3505, 2960, 2881, 2361, 2340, 1728, 1459, 
1381, 1237, 1169, 1124, 1035, 678 cm−1; 1H NMR (400 MHz, CDCl3) δ = 3.69 (s, 3H), 
3.75–3.63 (m, 2H), 2.87 (ddd, J = 18.1, 9.2, 5.7 Hz, 1H), 2.80–2.70 (m, 1H), 2.64–2.47 
(m, 2H), 2.33–2.03 (m, 5H), 1.91 (ddd, J = 14.7, 9.3, 5.7 Hz, 1H), 1.80–1.66 (m, 1H), 
1.10 (d, J = 7.2 Hz, 3H), 1.02 (d, J = 6.8 Hz, 3H); 13C NMR (63 MHz, CDCl3) δ = 216.8, 
214.1, 170.9, 64.7, 61.9, 52.0, 48.3, 42.4, 38.7, 37.0, 28.3, 26.5, 16.0, 13.3; HRMS (ESI) 
m/z calcd for C14H22NaO5 [M + Na]+: 293.1359, found: 293.1361. 
 
Methyl (1R,2R)-2-methyl-1-((E)-4-methyl-5-oxopent-3-en-1-yl)-5-oxocyclopentane-1-
carboxylate (38): To a solution of β-keto ester 7 (284 mg, 1.82 mmol, 1.0 eq) and 
α,β,γ,δ-unsaturated aldehyde 37 (4.0 mL, 2.00 mmol, 1.1 eq, 0.5 M solution in CH2Cl2) 
in acetone (10.0 mL) was added K2CO3 (503 mg, 3.64 mmol, 2.0 eq) and the mixture was 
heated to 30 °C overnight. After cooling to room temperature, the mixture was filtered 
through a short pad of celite. The solvent was removed and the residue was subjected to 
flash column chromatography (pentane/Et2O 3:1 to 2:1) to give 38 (319 mg, 1.26 mmol, 
70%) as colorless oil; Rf = 0.47 (pentane/Et2O 1:1); 𝛼 #%* = +55.2 (c 1.01, CHCl3); FTIR 
(neat): ν = 2958, 2361, 1730, 1685, 1645, 1436, 1406, 1356, 1232, 1168, 1124, 1042, 
994, 669 cm−1; 1H NMR (400 MHz, CDCl3) δ = 9.36 (s, 1H), 6.43 (td, J = 7.3, 1.4 Hz, 
1H), 3.69 (s, 3H), 2.63–2.51 (m, 2H), 2.30–2.18 (m, 3H), 2.15–1.96 (m, 2H), 1.84–1.74 
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(m, 2H), 1.72 (d, J = 1.1 Hz, 3H), 1.05 (d, J = 6.9 Hz, 3H); 13C NMR (101 MHz, CDCl3) 
δ = 216.0, 195.1, 170.6, 153.4, 139.7, 62.4, 51.9, 40.6, 38.6, 30.7, 28.1, 23.9, 15.8, 9.2; 
HRMS (ESI) m/z calcd for C14H20NaO4 [M + Na]+: 275.1254, found: 275.1255. 
 
Methyl (1R,5S,7R)-7-methyl-8-oxo-4-(1-oxopropan-2-yl)bicyclo[3.2.1]octane-1-
carboxylate (39): A 0.2 M stock solution of Me3AlSPhLi was prepared by adding Me3Al 
(2.0 M in toluene, 0.5 mL, 1.0 mmol) to a solution of PhSH (111 mg, 1.0 mmol) and n-
BuLi (1.6 M in hexane, 0.63 mL, 1.0 mmol) in THF (3.8 mL) at 0 °C. To a solution of 
α,β-unsaturated aldehyde 38 (50 mg, 0.198 mmol, 1.0 eq) in THF was added the stock 
solution (1.28 mL, 0.257 mmol, 1.3 eq) and the mixture was stirred at 40 °C for 3 h 
before it was poured into saturated NH4Cl solution. The layers were separated and the 
aqueous was extracted with CH2Cl2 (3 x). The combined organic layers were washed with 
water, dried over Na2SO4, filtered and concentrated. The residue was subjected to flash 
column chromatography (pentane/Et2O 1:1) to give 39 as colorless oil (18.4 mg, 
0.073 mmol, 37%, dr = 2:1); Rf = 0.28 (pentane/Et2O 1:1); FTIR (neat): ν = 3487, 2954, 
2875, 1750, 1725, 1450, 1380, 1341, 1295, 1274, 1231, 1194, 1030, 692 cm−1; 1H NMR 
(400 MHz, CDCl3) δ = 9.54 (d, J = 3.3 Hz, 1H), 9.49 (d, J = 3.3 Hz, 1H), 3.72 (s, 6H), 
2.50–2.08 (m, 12H), 1.98–1.87 (m, 2H), 1.82–1.70 (m, 2H), 1.62–1.48 (m, 2H), 1.44–
1.35 (m, 2H), 1.09 (d, J = 6.6 Hz, 3H), 1.05 (d, J = 6.8 Hz, 3H), 0.99 (d, J = 7.1 Hz, 3H), 
0.97 (d, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 213.9, 213.4, 203.4, 203.1, 
171.0, 170.9, 60.9, 60.4, 51.9, 49.8, 49.5, 49.1, 48.1, 46.7, 46.5, 38.2, 38.0, 36.2, 36.1, 
28.8, 28.5, 23.5, 21.7, 21.1, 21.1, 12.3, 12.2; HRMS (ESI) m/z calcd for C14H20NaO4 
[M + Na]+: 275.12538, found: 275.12529. 
 
Methyl (1R,2R)-2-methyl-5-oxo-1-(3-oxopropyl)cyclopentane-1-carboxylate (40): To a 
solution of β-keto ester 7 (95 mg, 0.608 mmol, 1.0 eq) in CH2Cl2 (5.0 mL) was added 
NEt3 (128 µL, 0.912 mmol, 1.5 eq), followed by acrolein (41 µL, 0.730 mmol, 1.2 eq). 
The mixture was stirred at room temperature for 4 h. The clear solution was filtered 
through a short pad of silica gel and washed with Et2O. The solvent was evaporated and 
the residue subjected to flash column chromatography (pentane/Et2O 2:1) to give 40 
(92.0 mg, 0.433 mmol, 71%) as colorless oil; Rf = 0.36 (pentane/Et2O 1:1); 𝛼 #%& = +64.7 
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(c 1.04, CHCl3); FTIR (neat): ν = 2958, 2839, 2727, 2361, 1722, 1437, 1386, 1236, 1166, 
1126, 1062, 996, 836, 763, 668 cm−1; 1H NMR (400 MHz, CDCl3) δ = 9.74 (s, 1H), 3.68 
(s, 3H), 2.91–2.76 (m, 1H), 2.60–2.45 (m, 2H), 2.31–2.00 (m, 4H), 1.99–1.84 (m, 1H), 
1.83–1.67 (m, 1H), 1.03 (d, J = 6.7 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ = 216.3, 
201.5, 170.7, 61.7, 52.1, 41.9, 39.3, 38.6, 28.3, 24.8, 15.9; HRMS (ESI) m/z calcd for 
C11H16NaO4 [M + Na]+: 235.0941, found: 235.0940. 
 
Methyl (1R,2R)-1-(3-hydroxy-4-methylpent-4-en-1-yl)-2-methyl-5-oxocyclopentane-1-
carboxylate (41): To a solution of aldehyde 40 (61.0 mg, 0.287 mmol, 1.0 eq) in THF 
(0.8 mL) at –78°C was added isopropylmagnesium bromide solution (0.5 M in THF, 
0.69 mL, 0.345 mmol, 1.2 eq). The mixture was allowed to stir at –78°C for 3 h, and was 
then quenched by addition of sat. aq. NH4Cl solution. Water and Et2O were added after 
warming up to room temperature and the layers were separated. The aqueous layer was 
extracted with Et2O (2 x) and the combined organic layers were washed with brine, dried 
over Na2SO4, filtered and concentrated. The residue was subjected to flash column 
chromatography (pentane/Et2O 1:1) to give 41 (24.0 mg, 0.094 mmol, 33%) as colorless 
oil; Rf = 0.57 (pentane/Et2O 1:2); 𝛼 #%) = +54.2 (c 0.78, CHCl3); FTIR (neat): ν = 3481, 
2958, 2879, 2361, 1730, 1451, 1382, 1329, 1234, 1165, 1125, 1061, 996, 900, 678 cm−1; 
1H NMR (400 MHz, CDCl3) δ = 4.97–4.93 (m, 1H), 4.87–4.82 (m, 1H), 4.02 (t, J = 6.3 
Hz, 1H), 3.67 (s, 3H), 2.60–2.49 (m, 1H), 2.31–2.12 (m, 2H), 2.12–2.00 (m, 1H), 1.85–
1.62 (m, 5H), 1.70 (s, 3H), 1.48–1.35 (m, 1H), 1.04 (d, J = 6.8 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ = 216.5, 171.1, 147.0, 111.5, 76.0, 62.7, 51.8, 40.1, 38.8, 29.3, 28.2, 
27.7, 17.5, 15.8; HRMS (ESI) m/z calcd for C14H22NaO4 [M + Na]+: 277.1410, found: 
277.1412. 
 
Methyl (1R,2R)-1-(3-hydroxypent-4-en-1-yl)-2-methyl-5-oxocyclopentane-1-carboxylate 
(42): To a solution of aldehyde 40 (50.0 mg, 0.236 mmol, 1.0 eq) in THF (1.0 mL) at –
78°C was added vinylmagnesium bromide solution (0.7 M in THF, 0.42 mL, 
0.294 mmol, 1.25 eq). The mixture was allowed to stir at –78°C for 4 h, and was then 
quenched by addition of sat. aq. NH4Cl solution. Water and Et2O were added after 
warming up to room temperature and the layers were separated. The aqueous layer was 
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extracted with Et2O (2 x) and the combined organic layers were washed with brine, dried 
over Na2SO4, filtered and concentrated. The residue was subjected to flash column 
chromatography (pentane/Et2O 1:1) to give 42 (12.0 mg, 0.050 mmol, 21%) as colorless 
oil: Rf = 0.44 (pentane/Et2O 1:3); 𝛼 #%) = +62.6 (c 0.52, CHCl3); FTIR (neat): ν = 3443, 
3081, 2957, 2879, 2361, 1729, 1435, 1404, 1328, 1234, 1165, 1121, 1061, 994, 924, 883, 
669 cm−1; 1H NMR (400 MHz, CDCl3) δ = 5.84 (ddd, J = 17.1, 10.4, 6.0 Hz, 1H), 5.23 
(dt, J = 17.2, 1.4 Hz, 1H), 5.11 (dt, J = 10.4, 1.3 Hz, 1H), 4.06 (q, J = 5.7 Hz, 1H), 3.67 
(s, 3H), 2.54 (ddd, J = 18.9, 8.6, 1.1 Hz, 1H), 2.30–2.13 (m, 2H), 2.11–2.01 (m, 1H), 
1.92–1.84 (m, 1H), 1.83–1.61 (m, 4H), 1.44–1.34 (m, 1H), 1.04 (d, J = 6.9 Hz, 3H); 13C 
NMR (101 MHz, CDCl3) δ = 216.6, 171.3, 140.8, 115.1, 73.2, 62.9, 51.9, 40.2, 38.9, 
31.6, 28.3, 27.7, 15.9; HRMS (ESI) m/z calcd for C13H20NaO4 [M + Na]+: 263.1254, 
found: 263.1255. 
 
Methyl (1R,2R)-1-(3-((4-methoxybenzyl)oxy)pent-4-en-1-yl)-2-methyl-5-
oxocyclopentane-1-carboxylate (43): To a solution of 42 (10.4 mg, 0.043 mmol, 1.0 eq) 
and 4-Methoxybenzyl-2,2,2-trichloroacetimidate (24.5 mg, 0.087 mmol, 2.0 eq) in 
CH2Cl2 (1.0 mL) at 0 °C was added Sc(OTf)3 (1.1 mg, 4 µmol, 5 mol%). The mixture was 
stirred for 1.5 h at 0 °C and then quenched with sat. aq. NaHCO3 solution and diluted 
with Et2O. The layers were separated and the aqueous was extracted with Et2O (3 x). The 
combined organic layers were dried over Na2SO4, filtered and concentrated. The residue 
was subjected to flash column chromatography (pentane/Et2O 2:1) to give 43 (13.7 mg, 
0.038 mmol, 88%) as colorless oil; Rf = 0.53 (pentane/Et2O 1:1); 𝛼 #%& = +28.7 (c 0.36, 
CHCl3); FTIR (neat): ν = 3728, 3728, 3703, 3629, 3600, 2956, 2361, 2340, 1749, 1613, 
1513, 1459, 1301, 1246, 1174, 1065, 1035, 995, 823, 679 cm−1; 1H NMR (400 MHz, 
CDCl3) δ = 7.26–7.22 (m, 2H), 6.86 (dd, J = 8.8, 2.4 Hz, 2H), 5.69 (ddd, J = 17.1, 10.6, 
7.6 Hz, 1H), 5.24 (d, J = 2.1 Hz, 1H), 5.20 (d, J = 8.7 Hz, 1H), 4.50 (d, J = 11.3 Hz, 1H), 
4.28 (d, J = 11.3 Hz, 1H), 3.80 (s, 3H), 3.72–3.67 (m, 1H), 3.66 (s, 3H), 2.52 (dd, J = 
18.7, 8.2 Hz, 1H), 2.32–2.21 (m, 1H), 2.21–2.11 (m, 1H), 2.08–1.98 (m, 1H), 1.90–1.66 
(m, 4H), 1.36–1.26 (m, 1H), 1.02 (d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 
216.5, 171.3, 159.2, 138.8, 130.9, 129.5, 117.7, 113.9, 80.6, 69.9, 63.0, 55.4, 51.9, 39.6, 
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39.1, 30.2, 28.3, 27.6, 16.0; HRMS (ESI) m/z calcd for C21H28NaO5 [M + Na]+: 383.1829, 
found: 383.1831. 
 
Methyl (1R,2R)-2-methyl-1-(4-methyl-3-oxopent-4-en-1-yl)-5-oxocyclopentane-1-
carboxylate (44): Dess-Martin periodinane (25 mg, 0.059 mmol, 1.5 eq) was added to a 
cold (0 °C) solution of allylic alcohol 41 (10.0 mg, 0.039 mmol, 1.0 eq) in CH2Cl2 
(1.0 mL). The mixture was stirred at room temperature for 1.5 h and then quenched by 
addition of sat. aq. Na2S2O3 and sat. aq. NaHCO3 solution. The layers were separated and 
the aqueous layer was extracted with CH2Cl2 (3 x). The combined organic layers were 
washed with water and brine, dried over Na2SO4, filtered and concentrated. The residue 
was subjected to flash column chromatography (pentane/Et2O 2:1) to give enone 44 
(8.0 mg, 0.032 mmol, 81%) as colorless oil; Rf = 0.86 (pentane/Et2O 1:2); 𝛼 #%) = +31.7 
(c 0.40, CHCl3); FTIR (neat): ν = 2958, 2362, 2340, 1730, 1677, 1631, 1455, 1375, 1337, 
1236, 1168, 1123, 1094, 1068, 1037, 939 cm−1; 1H NMR (400 MHz, CDCl3) δ = 5.99 (s, 
1H), 5.76 (d, J = 1.6 Hz, 1H), 3.69 (s, 3H), 3.06 (ddd, J = 16.9, 10.8, 4.9 Hz, 1H), 2.74 
(ddd, J = 16.9, 10.9, 5.0 Hz, 1H), 2.54 (ddd, J = 18.9, 8.5, 1.9 Hz, 1H), 2.32–2.13 (m, 
3H), 2.14–2.00 (m, 1H), 1.92 (ddd, J = 14.4, 10.8, 4.9 Hz, 1H), 1.86 (s, 3H), 1.83–1.67 
(m, 1H), 1.04 (d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 216.6, 171.3, 147.1, 
111.7, 76.1, 62.8, 51.9, 40.2, 38.9, 29.5, 28.3, 27.9, 17.6, 16.0; HRMS (ESI) m/z calcd 
for C14H20NaO4 [M + Na]+: 275.12538, found: 275.12535. 
 
Methyl (1R,2R)-2-methyl-5-oxo-1-(3-oxopent-4-en-1-yl)cyclopentane-1-carboxylate (45): 
Dess-Martin periodinane (38.2 mg, 90 µmol, 1.5 eq) was added to a cold (0 °C) solution 
of allylic alcohol 42 (14.4 mg, 0.06 mmol, 1.0 eq) in CH2Cl2 (1.0 mL). The mixture was 
stirred at room temperature for 4 h and then quenched by addition of sat. aq. Na2S2O3 and 
sat. aq. NaHCO3 solution. The layers were separated and the aqueous was extracted with 
CH2Cl2 (3 x). The combined organic layers were washed with water and brine, dried over 
Na2SO4, filtered and concentrated. The residue was subjected to flash column 
chromatography (pentane/Et2O 2:1) to give enone 45 (9.4 mg, 39 µmol, 65%) as colorless 
oil; Rf = 0.53 (pentane/Et2O 1:1); 𝛼 #%) = +39.6 (c 0.47, CHCl3); FTIR (neat): ν = 2959, 
2361, 1728, 1617, 1436, 1404, 1236, 1168, 1123, 1067, 992, 907 cm−1; 1H NMR (400 
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MHz, CDCl3) δ = 6.34 (dd, J = 17.7, 10.2 Hz, 1H), 6.24 (dd, J = 17.6, 1.5 Hz, 1H), 5.83 
(dd, J = 10.2, 1.5 Hz, 1H), 3.70 (s, 3H), 3.00 (ddd, J = 17.3, 10.7, 4.9 Hz, 1H), 2.66 (ddd, 
J = 17.3, 10.7, 5.0 Hz, 1H), 2.54 (ddd, J = 19.0, 8.6, 1.8 Hz, 1H), 2.32–2.14 (m, 3H), 
2.13–2.03 (m, 1H), 1.92 (ddd, J = 14.5, 10.8, 4.9 Hz, 1H), 1.84–1.68 (m, 1H), 1.05 (d, J = 
6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 216.5, 200.2, 170.9, 136.5, 128.4, 61.9, 
52.0, 42.2, 38.7, 34.7, 28.4, 26.9, 16.0; HRMS (ESI) m/z calcd for C13H18NaO4 
[M + Na]+: 261.1097, found: 261.1099. 
 
Methyl (1R,2R)-1-((E)-3-hydroxy-6-(trimethylsilyl)hex-4-en-1-yl)-2-methyl-5-
oxocyclopentane-1-carboxylate (46): To a degassed solution of allylic alcohol 42 
(27.9 mg, 0.120 mmol, 1.0 eq) and allyltrimethyl silane (137 mg, 0.120 mmol, 10 eq) in 
CH2Cl2 (1.5 mL) was added Grubbs 2nd generation catalyst (5.00 mg, 6 µmol, 5.0 mol%). 
The mixture was heated for 4 h at 40 °C and then filtered through a short pad of silica 
(eluted with CH2Cl2). The solvent was removed under reduced pressure and the residue 
was subjected to flash column chromatography (pentane/Et2O 2:1 to 1:1) to give 46 
(20.1 mg, 0.062 mmol, 51%) as colorless oil; Rf = 0.54 (pentane/Et2O 1:3); 𝛼 #%& = +30.5 
(c 1.01, CHCl3); FTIR (neat): ν = 3444, 2955, 2361, 1731, 1457, 1405, 1245, 1162, 1122, 
1059, 996, 966, 849, 755, 695 cm−1; 1H NMR (400 MHz, CDCl3) δ = 5.63 (dt, J = 15.6, 
8.2 Hz, 1H), 5.28 (dd, J = 15.2, 7.4 Hz, 1H), 3.98 (q, J = 6.7 Hz, 1H), 3.66 (s, 3H), 2.53 
(dd, J = 18.8, 8.5 Hz, 1H), 2.31–2.13 (m, 2H), 2.09–2.01 (m, 1H), 1.88–1.61 (m, 5H), 
1.45 (d, J = 8.2 Hz, 2H), 1.35–1.26 (m, 1H), 1.03 (d, J = 6.8 Hz, 3H), -0.01 (s, 9H); 13C 
NMR (101 MHz, CDCl3) δ = 216.5, 171.3, 131.2, 129.6, 73.7, 62.9, 51.9, 40.0, 39.0, 
32.0, 28.3, 27.9, 22.9, 15.9, -1.8; HRMS (ESI) m/z calcd for C17H30NaO4Si [M + Na]+: 
349.1806, found: 349.1805. 
 
Methyl (1R,2R)-2-methyl-5-oxo-1-((E)-3-oxo-6-(trimethylsilyl)hex-4-en-1-
yl)cyclopentane-1-carboxylate (48): To a degassed solution of enone 45 (9.4 mg, 
0.039 mmol, 1.0 eq) and allyltrimethyl silane (45 mg, 0.39 mmol, 10 eq) in CH2Cl2 
(0.5 mL) was added Grubbs 2nd generation catalyst (1.65 mg, 2 µmol, 5.0 mol%) The 
mixture was heated for 1 h at 40 °C and then filtered through a short pad of silica (eluted 
with CH2Cl2). The solvent was removed under reduced pressure and the residue was 
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subjected to flash column chromatography (pentane/Et2O 3:1) to give 48 (9.2 mg, 
0.028 mmol, 73%) as colorless oil; Rf = 0.58 (pentane/Et2O 1:1); 𝛼 #%) = +21.6 (c 0.46, 
CHCl3); FTIR (neat): ν = 2956, 2921, 2361, 1730, 1660, 1613, 1436, 1408, 1380, 1328, 
1292, 1246, 1196, 1167, 1125, 1040, 979, 847, 756, 698, 669 cm−1; 1H NMR (400 MHz, 
CDCl3) δ = 6.97 (dt, J = 15.5, 8.8 Hz, 1H), 5.94 (dt, J = 15.7, 1.2 Hz, 1H), 3.69 (s, 3H), 
2.84 (ddd, J = 16.1, 10.9, 4.9 Hz, 1H), 2.59–2.49 (m, 2H), 2.30–2.02 (m, 4H), 1.98–1.88 
(m, 1H), 1.80–1.71 (m, 3H), 1.04 (d, J = 6.8 Hz, 3H), 0.05 (s, 9H); 13C NMR (101 MHz, 
CDCl3) δ = 216.5, 199.3, 171.0, 147.0, 128.6, 62.1, 52.0, 41.8, 38.7, 35.0, 28.3, 27.3, 
25.4, 16.0, -1.6; HRMS (ESI) m/z calcd for C17H28NaO4Si [M + Na]+: 347.1649, found: 
347.1650. 
 
Methyl (1R,2R)-2-methyl-1-(2-(4-methyl-2-oxo-2,5-dihydrofuran-3-yl)ethyl)-5-
oxocyclopentane-1-carboxylate (49): Ester 11 (516.0 mg, 1.25 mmol, 1.0 eq.) and 
Fe(acac)3 (22.0 mg, 62.3 μmol, 5 mol%) were added to a dry and degassed solution of 
THF (12.0 mL) and NMP (0.6 mL) and the reaction mixture was cooled to –30 °C. The 
mixture was stirred for 10 minutes at this temperature and MeMgBr (3.2 M in THF, 545 
μl, 1.74 mmol, 1.4 eq.) was rapidly added to the orange solution. The color of the mixture 
turned into a brown to green mixture, which finally resulted in a colorless solution with a 
brown precipitate. The reaction was quenched after 1 h with saturated NH4Cl solution at –
30 °C. The mixture was allowed to warm up to rt, water was added and the organic layer 
was separated. The aqueous layer was extracted with EtOAc (4 x 20 mL) and the 
combined organic layers were dried over Na2SO4, filtered and evaporated under reduced 
pressure. The residue was purified by flash chromatography (pentane/EtOAc 2:1 then 
1:1) to obtain the desired β-methyl lactone 49 (333.9 mg, 1.19 mmol, 96%) as colorless 
oil; Rf = 0.24 (EtOAc/pentane 1:2); 𝛼 #%)	= +61.0 (c 0.29, CHCl3); FTIR (neat): ν = 2985, 
1743, 1678, 1451, 1228, 1166, 1032, 762 cm-1; 1H NMR (400 MHz, CDCl3) δ = 4.61 (s, 
2H), 3.69 (s, 3H), 2.59–2.45 (m, 2H), 2.42–2.32 (m, 1H), 2.29–2.08 (m, 3H), 2.05 (brs, 
3H), 1.92–1.87 (m, 2H), 1.85–1.73 (m, 1H), 1.07 (d, J = 6.8 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ = 216.4, 174.9, 171.0, 157.7, 127.0, 72.7, 62.7, 52.0, 40.3, 38.9, 30.6, 
28.4, 18.4, 16.1, 12.3; HRMS (ESI) m/z calcd for C15H21O5 [M + H]+: 281.1384, found: 
281.1383.  
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Methyl (3aR,5aR,6R,8aR,8bS)-8a-hydroxy-6,8b-dimethyl-3-oxodecahydro-5aH-
indeno[4,5-c]furan-5a-carboxylate (26) and methyl (1R,5R)-2-hydroxy-5-methyl-1-(2-(4-
methyl-2-oxo-2,5-dihydrofuran-3-yl)ethyl)cyclopentane-1-carboxylate (66): The 
methylester 49 (40.4 mg, 144 mmol, 1.0 eq) was dissolved in dry THF (0.59 ml) and 
water (17.6 ml) (both solvents were separately freeze-thawed, three cycles). SmI2 (3.60 
ml, 360 mmol, 2.5 eq, 0.1 M solution in THF, purchased from Sigma-Aldrich) was added 
over 1 h at room temperature by syringe-pump and stirred for 12 h at room temperature. 
The colorless solution was quenched with Rochelle's salt (saturated, 1.3 ml) and stirred 
for 30 minutes at rt. The mixture was extracted with EtOAc (4 x 10 ml) and the combined 
organic layers were washed with brine (1 x 5 ml), dried over MgSO4, filtered and 
evaporated to obtain a yellow oil. The mixture was purified by flash column 
chromatography (5:1, 4:1 then 2:1) to obtain the desired cyclized product 26 as white 
solid (20.5 mg, 50.4 mmol, 50%, dr 5:2) and reduced alcohol 66 (see supporting 
information) as colorless oil (15.8 mg, 38.9 mmol, 39%, dr = 10:1); the analytical data for 
the tricyclic product 26 matched those reported above. Analytical data for the alcohol 
byproduct 66: colorless oil (39%); Rf = 0.17 (pentane/EtOAc 2:1); 𝛼 #%&	= −47.4 (c 1.53, 
CHCl3); FTIR (neat): ν = 3468, 2956, 2869, 1721, 1676, 1448, 1261, 1191, 1091, 1036, 
802 cm-1; 1H NMR (600 MHz, CDCl3) δ = 4.63 (bs, 2H), 4.58 (dd, J = 6.6, 2.9 Hz, 1H), 
3.70 (s, 3H), 2.38−2.31 (m, 2H), 2.19 (t, J = 11.8 Hz, 1H) 2.09–2.04 (m, 1H), 2.04 (s, 
3H), 1.99–1.92 (m, 2H), 1.66–1.60 (m, 2H), 1.25–1.18 (m, 1H), 0.89 (d, J = 6.9 Hz, 3H); 
13C NMR (150 MHz, CDCl3) δ = 176.1, 174.7, 156.6, 127.4, 75.3, 73.0, 61.5, 51.3, 41.6, 
32.7, 30.8, 29.7, 19.8, 15.8, 12.3; HRMS (ESI) m/z calcd for C15H22O5Na [M + Na]+: 
305.1359, found: 305.1359.  
 
Methyl (1R,2R)-1-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-methyl-5-(propan-2-ylidene)-
cyclopentane-1-carboxylate (51): Freshly distilled diisopropylamine (20.0 mL, 135 
mmol, 1.4 eq.) was added to dry THF (50 mL) and cooled to –78 °C. n-BuLi (1.6 M in 
hexane, 79.0 mL, 126 mmol, 1.3 eq.) was slowly added to the solution and stirred for 
15 min at this temperature. The reaction mixture was allowed to warm up to 0 °C and was 
stirred for 1 h at this temperature. The solution was cooled to –78 °C, methyl (2R)-2-
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methyl-5-(propan-2-ylidene)cyclopentane-1-carboxylate (17.6 g, 97.0 mmol, 1.0 eq.) and 
dry DMPU (62.0 g, 59.0 mL, 483 mmol, 5.0 eq.) were added slowly to the solution and 
stirred for 15 min at this temperature and then for 1 h at 0 °C. The yellow solution was 
cooled to –78 °C and a solution of tert-butyl(2-iodoethoxy)dimethylsilane41 (33.2 g, 116 
mmol, 1.2 eq.) in dry THF (50 mL) was added to the reaction mixture. The mixture was 
stirred for 1 h at this temperature and then was allowed to warm up to rt over 1 h. The 
reaction was quenched with aq. HCl soln. (1 M, 200 mL). The aqueous layer was 
extracted with Et2O (4 x 150 mL). The combined organic layers were washed with brine 
(100 mL), dried over Na2SO4, filtered and the solvent was removed under reduced 
pressure. The residue was purified by flash column chromatography (pentane/Et2O 40:1, 
then 20:1 and 8:1) to afford the alkylated ester 51 (25.3 g, 74.4 mmol, 77%) as yellow oil; 
Rf = 0.24 (pentane/Et2O 40:1); 𝛼 #%&	= +37.8 (c 0.79, CHCl3); FTIR (neat): ν = 2953, 
2933, 2858, 1727, 1462, 1434, 1253, 1218, 1186, 1155, 1095, 1004, 837, 775, 631 cm–1; 
1H NMR (400 MHz, CDCl3) δ = 3.63 (s, 3H), 3.62–3.53 (m, 2H), 2.49 (dd, J = 15.4, 7.3 
Hz, 1H), 2.29–2.17 (m, 2H), 2.17–2.04 (m, 1H), 1.96 (ddd, J = 14.2, 9.0, 6.4 Hz, 1H), 
1.77–1.69 (m, 1H), 1.64 (d, J = 1.7 Hz, 3H), 1.62–1.53 (m, 1H), 1.50 (d, J = 1.7 Hz, 3H), 
0.90–0.89 (m, 3H), 0.88 (s, 9H), 0.03 (d, J = 1.7 Hz, 6H); 13C NMR (101 MHz, CDCl3) δ 
= 176.6, 137.7, 125.0, 60.4, 57.2, 51.4, 44.6, 36.9, 32.6, 32.2, 26.1, 22.4, 20.6, 18.4, 14.9, 
–5.1, –5.1; HRMS (ESI) m/z calcd for C19H37O3Si [M + H]+ 341.2506, found: 341.2507. 
 
Methyl (1R,2R)-1-(2-hydroxyethyl)-2-methyl-5-(propan-2-ylidene)cyclopentane-1-
carboxylate (52): The protected alcohol 51 (2.32 g, 6.81 mmol, 1.0 eq.) was dissolved in 
dry THF (50 mL) and cooled to 0 °C. Acetic acid (1.0 mL) and TBAF (1.0 M in THF, 
6.81 ml, 6.81 mmol, 1.0 eq.) were slowly added. The solution was allowed to warm up to 
rt and stirred for 18 h. The solution was cooled to 0 °C and quenched with aq. sat. 
NaHCO3 solution (80 mL). The aqueous layer was extracted with Et2O (3 x 100 mL) and 
the combined organic layers were washed with brine (50 mL). The organic layer was 
dried over Na2SO4, filtered and evaporated under reduced pressure. The crude was 
purified by flash column chromatography (pentane/Et2O 1:1) to obtain the alcohol 52 
(1.22 g, 5.39 mmol, 79%) as a slightly yellow oil; Rf = 0.27 (pentane/Et2O 1:1); 𝛼 #%& = 
+35.4 (c 0.43, CHCl3); FTIR (neat): ν = 3428, 2952, 2334, 1725, 1457, 1226, 1032, 891, 
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768 cm-1; 1H NMR (400 MHz, CDCl3) δ = 3.75–3.62 (m, 2H), 3.66 (s, 3H), 2.52 (dd, J = 
15.6, 7.1 Hz, 1H), 2.29–1.99 (m, 5H), 1.83–1.74 (m, 1H), 1.65 (d, J = 1.9 Hz, 3H), 1.54 
(dd, J = 2.8, 1.0 Hz, 3H), 1.53–1.46 (m, 1H), 0.92 (d, J = 6.9 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ = 177.3, 138.7, 125.5, 59.9, 57.4, 51.7, 44.6, 37.8, 32.8, 32.0, 22.5, 20.7, 
15.3; HRMS (ESI) m/z calcd for C13H23O3 [M + H]+: 227.1642, found: 227.1642.  
 
Methyl (1R,2R)-2-methyl-1-(2-oxoethyl)-5-(propan-2-ylidene)cyclopentane-1-carboxylate 
(53): Alcohol 52 (3.35 g, 14.8 mmol, 1.0 eq.) was dissolved in dry CH2Cl2 (150 mL), 
DMP (7.05 g, 16.3 mmol, 1.1 eq.) was added and the reaction mixture was stirred for 2 h 
at rt. Sat. aq. NaHCO3 solution (50 mL) was added and the aqueous layer was extracted 
with CH2Cl2 (5 x 50 mL). The combined organic layers were washed with brine (25 mL), 
dried over Na2SO4, filtered and the solvent was removed under reduced pressure. The 
residue was purified by flash column chromatography (pentane/Et2O 4:1) to obtain the 
aldehyde 53 (2.95 g, 13.2 mmol, 89%) as colorless oil; Rf = 0.38 (pentane/Et2O 5:1); 𝛼 #%)	= +23.6 (c 0.59, CHCl3); FTIR (neat): ν = 2952, 2735, 2361, 1722, 1457, 1222, 
1058, 892, 767 cm-1; 1H NMR (400 MHz, CDCl3) δ = 9.66 (t, J = 2.9 Hz, 1H), 3.68 (s, 
3H), 2.93 (dd, J = 16.1, 2.8 Hz, 1H), 2.74 (dd, J = 16.1, 3.1 Hz, 1H), 2.56 (dd, J = 15.8, 
7.5 Hz, 1H), 2.31–2.13 (m, 2H), 1.89–1.79 (m, 1H), 1.66 (d, J = 1.7 Hz, 3H), 1.61 (m, 
1H), 1.56 (dd, J = 2.6, 1.1 Hz, 3H), 0.93 (d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ = 202.5, 175.3, 137.4, 126.6, 56.2, 51.9, 48.3, 45.9, 32.6, 32.0, 22.6, 20.7, 14.6; 
HRMS (ESI) m/z calcd for C13H21O3 [M + H]+: 225.1485, found: 225.1485.  
 
Methyl (1R,2R)-1-(4-ethoxy-2,4-dioxobutyl)-2-methyl-5-(propan-2-ylidene)cyclopentane-
1-carboxylate (54): Ethyl diazoacetate (3.08 g, 26.4 mmol, 2.0 eq.) was dissolved in dry 
CH2Cl2 (25 mL), SnCl2 (255 mg, 1.32 mmol, 0.1 eq.) was added and the reaction mixture 
was stirred at rt. A solution of the aldehyde 53 (2.95 g, 13.2 mmol, 1.0 eq.) in dry CH2Cl2 
(30 mL) was added dropwise to the mixture. The color changed to yellow and formation 
of N2 was observed. The reaction mixture was stirred for 12 h at rt, then it was diluted 
with CH2Cl2 (50 mL), filtered over celite and the solvent was removed under reduced 
pressure. The residue was purified by flash column chromatography (pentane/Et2O 7:1 to 
2:1) to obtain the b-keto ester 54 (3.82 g, 12 mmol, 93%) as slightly orange oil; Rf = 0.24 
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(pentane/Et2O 5:1); 𝛼 #%)	= +49.6 (c 0.75, CHCl3); FTIR (neat): ν = 2950, 1717, 1644, 
1454, 1306, 1224, 1183, 1155, 1033 cm-1; (ratio keto ester/enol ester 10:1, only the data 
for the keto ester 54 is reported for the NMR set) 1H NMR (400 MHz, CDCl3) δ = 4.17 
(q, J = 7.1 Hz, 2H), 3.65 (d, J = 1.8 Hz, 3H), 3.41 (d, J = 5.5 Hz, 2H), 3.23 (d, J = 16.7 
Hz, 1H), 2.95 (d, J = 16.7 Hz, 1H), 2.57–2.41 (m, 2H), 2.41–2.25 (m, 1H), 1.85–1.73 (m, 
1H), 1.66–1.61 (m, 3H), 1.55–1.46 (m, 1H), 1.52 (d, J = 1.5 Hz, 3H), 1.26 (t, J = 7.1 Hz, 
3H), 0.85 (d, J = 6.9 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 201.2, 175.8, 167.3, 
138.5, 124.6, 61.4, 56.9, 51.7, 50.8, 46.6, 43.6, 32.8, 31.9, 22.5, 20.5, 14.7, 14.2; HRMS 
(ESI) m/z calcd for C17H27O5 [M + H]+: 311.1853, found: 311.1855.  
 
6-Ethyl 3a-methyl (3R,3aR,6R)-6-chloro-3,7,7-trimethyl-5-oxo-2,3,4,5,6,7-hexahydro-
3aH-indene-3a,6-dicarboxylate (55): b-Keto ester 54 (40.0 mg, 129 µmol, 1.0 eq.) was 
dissolved in degassed Ac2O (3.0 mL, freeze-thaw method, 3 cycles). Flame dried LiCl 
(54.7 mg, 1.29 mmol, 10 eq.) was added and the reaction mixture was heated to 50 °C. 
Mn(OAc)3 · 2 H2O (141 mg, 516 µmol, 4.0 eq.) was added and the reaction mixture was 
stirred for 5 h at this temperature. Dist. water (5 mL) was added and the mixture was 
extracted with EtOAc (5 x 5 mL). The combined organic layers were washed with brine 
(5 mL), dried over Na2SO4, filtered and evaporated under reduced pressure. The residue 
was purified by flash column chromatography (pentane/Et2O 6:1 to 3:1) to obtain the 
oxo-dicarboxylate 55 (17.1 mg, 50 µmol, 39%) as white solid; Mp: 66.2–67.8 °C; Rf = 
0.26 (pentane/Et2O 6:1); 𝛼 #%)	= –53.2 (c 0.73, CHCl3); FTIR (neat): ν = 2982, 2931, 
1728, 1459, 1408, 1385, 1366, 1346, 1246, 1225, 1105, 1034, 979, 894, 833, 757, 708, 
606 cm-1; 1H NMR (400 MHz, CDCl3) δ = 5.91–5.90 (m, 1H), 4.36–4.21 (m, 2H), 3.68 
(s, 3H), 3.49 (d, J = 15.3 Hz, 1H), 2.99 (d, J = 15.5 Hz, 1H), 2.55–2.42 (m, 2H), 2.35– 
2.23 (m, 1H), 1.38 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H), 1.21 (s, 3H), 0.97 (d, J = 6.7 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ = 199.7, 173.9, 165.8, 146.1, 129.9, 79.0, 62.7, 60.2, 52.1, 
50.8, 45.2, 43.6, 39.2, 24.1, 22.1, 14.2, 14.1; HRMS (ESI) m/z calcd for C17H24O5Cl [M + 
H]+: 343.1307, found: 343.1308.  
 
6-Ethyl 3a-methyl (3R,3aR,5R,6R)-6-chloro-5-hydroxy-3,7,7-trimethyl-2,3,4,5,6,7-hexa-
hydro-3aH-indene-3a,6-dicarboxylate (56): The oxo-dicarboxylate 55 (1.05 g, 
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3.05 mmol, 1.0 eq.) was dissolved in dry MeOH (50 mL). The solution was cooled to 
0 °C and NaBH4 (294 mg, 7.63 mmol, 2.5 eq.) was added in small portions. The reaction 
mixture was stirred at 0 °C for 1 h, then the cooling bath was removed and the reaction 
mixture was allowed to stir for 3 h at rt. The reaction mixture was cooled to 0 °C and 
quenched with brine (50 mL). The aqueous layer was extracted with EtOAc (5 x 50 mL) 
and the combined organic layers were washed with brine (30 mL). The organic layers 
were dried over Na2SO4, filtered and evaporated under reduced pressure. The residue was 
purified by flash column chromatography (pentane/Et2O 6:1 to 3:1) to afford the 
hydroxy-dicarboxylate 56 (904 mg, 2.6 mmol, 86%) as white solid; Mp: 82.1–83.0 °C; Rf 
= 0.14 (pentane/Et2O 6:1); 𝛼 #%&	= +42.4 (c 0.28, CHCl3); FTIR (neat): ν = 3457, 2967, 
2929, 2338, 1734, 1692, 1450, 1409, 1384, 1363, 1284, 1239, 1193, 1105, 1088, 1032, 
995, 912, 887, 853, 819, 757, 702, 627 cm-1; 1H NMR (400 MHz, CDCl3) δ = 5.87 (dd, J 
= 3.2, 1.7 Hz, 1H), 4.50 (s, 1H), 4.36–4.21 (m, 3H), 3.69 (s, 3H), 2.88 (dd, J = 14.7, 2.8 
Hz, 1H), 2.42 (ddd, J = 14.9, 7.4, 3.1 Hz, 1H), 2.32–2.20 (m, 1H), 2.17 (ddd, J = 14.9, 
10.3, 1.7 Hz, 1H), 2.03 (dd, J = 14.8, 3.7 Hz, 1H), 1.53 (s, 3H), 1.38–1.31 (m, 6H), 0.97 
(d, J = 6.9 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 176.6, 170.7, 147.6, 129.6, 75.0, 
74.2, 62.2, 56.4, 51.7, 49.9, 42.3, 38.9, 35.8, 26.5, 26.1, 14.7, 14.1; HRMS (ESI) m/z 
calcd for C17H26O5Cl [M + H]+: 345.1463, found: 345.1462; X-ray crystal structure is 
given in the supporting information. 
 
9-Ethyl 5a-methyl (1R,4R,5aR,6R,9R)-9-chloro-1,6-dimethyl-1,2,4,5,6,7-hexahydro-5aH-
1,4-methanocyclopenta[d]oxepine-5a,9-dicarboxylate (57) and 9-Ethyl 5a-
methyl (1R,2R,4R,5aR,6R,9R)-2-acetoxy-9-chloro-1,6-dimethyl-1,2,4,5,6,7-hexahydro-
5aH-1,4-methanocyclopenta[d]oxepine-5a,9-dicarboxylate (58): Hydroxy-dicarboxylate 
56 (3.48 g, 10.1 mmol, 1.0 eq.) was dissolved in degassed cyclohexane (200 mL, freeze-
thaw method, 3 cycles). Pb(IV) acetate (11.5 g, 25.2 mmol, 2.5 eq.), iodine (6.54 g, 
25.2 mmol, 2.5 eq.) and CaCO3 (4.04 g, 40.4 mmol, 4.0 eq.) were added. The reaction 
mixture was stirred at rt under irradiation of Hg-light (low pressure lamp) for three days 
and Pb(IV) acetate (45.7 g, 101 mmol, 10 eq.), iodine (26.2 g, 101 mmol, 10 eq.) and 
CaCO3 (10.3 g, 101 mmol. 10 eq.) were added in four equal portions (each 2.5 eq.) during 
this time. The violet reaction mixture was cooled to 0 °C and sat. aq. Na2S2O3 (400 mL) 
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was added until the mixture turned colorless. The mixture was extracted with EtOAc (4 x 
200 mL), washed with brine (100 mL), dried over Na2SO4, filtered and evaporated under 
reduced pressure. The crude was purified by flash column chromatography (pentane/Et2O 
5:1 to 3:1) to afford the chloro-furan 57 (major product) (2.82 g, 8.2 mmol, 81%) as 
colorless solid and furan-acetate 58 (minor product) (600 mg, 1.5 mmol, 15%) as 
colorless solid; 57: Mp: 96.5–97.1 °C; Rf = 0.16 (pentane/Et2O 4:1); 𝛼 #%)	= –50.5 (c 
0.37, CHCl3); FTIR (neat): ν = 2961, 2945, 2906, 2360, 1736, 1721, 1453, 1383, 1228, 
1081, 1031, 981, 936, 876, 772, 726 cm-1; 1H NMR (400 MHz, CDCl3) δ = 5.83 (s, 1H), 
4.71 (d, J = 4.8 Hz, 1H), 4.24 (q, J = 7.1 Hz, 1H), 3.85 (dd, J = 8.1, 0.8 Hz, 1H), 3.72–
3.66 (m, 3H), 3.59 (d, J = 8.2 Hz, 1H), 3.07 (dd, J = 14.4, 4.9 Hz, 1H), 2.46–2.32 (m, 
2H), 2.21–2.02 (m, 1H), 1.90 (d, J = 14.2 Hz, 1H), 1.35 (s, 3H), 1.29 (td, J = 7.1, 0.8 Hz, 
3H), 0.91 (d, J = 6.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 173.8, 168.5, 145.6, 
129.8, 79.6, 73.7, 73.6, 62.4, 57.5, 51.8, 49.5, 48.7, 39.4, 37.0, 15.1, 14.1, 13.4; HRMS 
(ESI) m/z calcd for C17H23O5ClNa [M + Na]+: 365.1126, found: 365.1125; X-ray crystal 
structure is given in the supporting information; 58: Mp: 130.5–131.5 °C; Rf = 0.31 
(pentane/Et2O 2:1); 𝛼 #%)	= +31.8 (c 0.57, CHCl3); FTIR (neat): ν = 2959, 1755, 1724, 
1440, 1377, 1255, 1218, 1178, 1078, 1019, 991, 934, 882, 776, 738 cm-1; 1H NMR (500 
MHz, CDCl3) δ = 6.04–6.02 (m, 1H), 5.97 (s, 1H), 5.15 (d, J = 4.5 Hz, 1H), 4.33–4.18 
(m, 2H), 3.73 (s, 3H), 3.12 (dd, J = 14.4, 5.2 Hz, 1H), 2.46–2.37 (m, 2H), 2.18–2.09 (m, 
1H), 1.97 (s, 3H), 1.90 (dd, J = 14.5, 0.8 Hz, 1H), 1.43 (s, 3H), 1.34 (t, J = 7.1 Hz, 3H), 
0.94 (d, J = 6.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 173.4, 169.0, 168.0, 142.8, 
132.9, 97.6, 80.1, 71.2, 62.4, 57.6, 54.0, 52.1, 48.5, 39.3, 36.0, 21.1, 15.2, 14.1, 12.5; 
HRMS (ESI) m/z calcd for C19H25O7ClNa [M + Na]+: 423.1181, found: 423.1188; X-ray 
crystal structure is given in the supporting information. 
 
Conversion of acetyl-furan 58 to chloro-furan 57: Acetyl-furan 58 (702 mg, 1.75 mmol, 
1.0 eq.) was dissolved in dry CH2Cl2 (120 mL) and cooled to –78 °C. Triethylsilane (514 
mg, 4.38 mmol, 2.5 eq.) and boron trifluoride etherate (621 mg, 4.38 mmol, 2.5 eq.) were 
added. The reaction mixture was stirred 1 h at –78 °C and then was allowed to warm up 
to rt over a period of 12 h. The reaction mixture was cooled to 0 °C and dist. water (80 
mL) was slowly added. The mixture was extracted with Et2O (3 x 80 mL), washed with 
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brine (50 mL), dried over Na2SO4, filtered and evaporated under reduced pressure. The 
crude was purified by flash column chromatography (pentane/Et2O 4:1) to afford the 
chloro-furan 57 (525 mg, 1.53 mmol, 88%) as colorless solid. 
 
9-Ethyl 5a-methyl (1R,4R,5aR,6R,9S)-1,6-dimethyl-1,2,4,5,6,7-hexahydro-5aH-1,4-
methanocyclopenta[d]oxepine-5a,9-dicarboxylate (59):  Chloro-furan 57 (483 mg, 
1.41 mmol, 1.0 eq.) was dissolved in dry benzene (35 mL). Sn(Bu)3H (487 mg, 1.62 
mmol, 1.15 eq.) and AIBN (23.9 mg, 0.14 mmol, 0.1 eq.) were added to the reaction 
mixture. The reaction mixture was heated to 100 °C and stirred for 2 h. The reaction was 
cooled to rt and then evaporated under reduced pressure. The residue was purified by 
flash column chromatography (pentane/Et2O 3:1) to afford the hydro-furan 59 (411 mg, 
1.34 mmol, 95%) as colorless oil; Rf = 0.16 (pentane/Et2O 3:1); 𝛼 #%)	= +9.0 (c 0.78, 
CHCl3); FTIR (neat) ν = 2955, 2880, 1725, 1450, 1378, 1337, 1196, 1155, 1049, 1023, 
989, 925, 664, 627 cm-1; 1H NMR (400 MHz, CDCl3) δ = 5.72 (s, 1H), 4.56 (t, J = 5.2 
Hz, 1H), 4.20–4.04 (m, 2H), 3.78 (d, J = 7.7 Hz, 1H), 3.69 (s, 3H), 3.46 (d, J = 7.7 Hz, 
1H), 3.01 (dd, J = 14.2, 4.7 Hz, 1H), 2.83 (dd, J = 5.9, 1.1 Hz, 1H), 2.39–2.23 (m, 2H), 
2.13–2.03 (m, 1H), 1.71 (d, J = 14.5 Hz, 1H), 1.35 (s, 3H), 1.23 (t, J = 7.1 Hz, 3H), 0.90 
(d, J = 6.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 174.3, 169.7, 145.8, 126.6, 77.4, 
76.7, 60.3, 58.3, 55.7, 51.7, 48.9, 44.8, 39.0, 37.7, 17.4, 15.2, 14.4; HRMS (ESI) m/z 
calcd for C17H25O5 [M + H]+: 309.1697, found: 309.1698.  
 
6-Ethyl 3a-methyl (3R,3aR,6S,7R)-5-acetoxy-7-(acetoxymethyl)-3,7-dimethyl-2,3,4,5,6,7-
hexahydro-3aH-indene-3a,6-dicarboxylate (60) and 
6-Ethyl 3a-methyl (3R,3aS,7R)-7-(acetoxymethyl)-3,7-dimethyl-2,3,6,7-tetrahydro-3aH-
indene-3a,6-dicarboxylate (61): Hydro-furan 59 (44.7 mg, 145 µmol, 1.0 eq.) was 
dissolved in Ac2O (0.9 mL). The solution was cooled to –20 °C and boron trifluoride 
etherate (56.2 µL, 435 µmol, 3.0 eq.) was added. The reaction was allowed to warm up to 
rt over 12 h. The reaction mixture was cooled to 0 °C and dist. water (1.0 mL) was added 
dropwise. The reaction mixture was stirred for 10 min and warmed up to rt. The mixture 
was extracted with Et2O (3 x 1.5 mL), washed with brine (1.5 mL), dried over Na2SO4, 
filtered and evaporated under reduced pressure. The residue was purified by flash column 
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chromatography (pentane/Et2O 2:1) to afford the diacetylated compound 60 (35.4 mg, 87 
µmol, 60%) as a yellow oil and the monoacetylated compound 61 (31.7 mg, 46 µmol, 
32%) as colorless oil; 60: Rf = 0.17 (pentane/Et2O 2:1); 𝛼 #%)	= +8.9  (c 0.34, CHCl3); 
FTIR (neat): ν = 3480, 2956, 1727, 1440, 1367, 1224, 1028, 908, 790, 664 cm-1; 1H NMR 
(400 MHz, CDCl3) δ = 5.83 (s, 1H), 5.30–5.23 (m, 1H), 4.19–4.03 (m, 2H), 3.77 (d, J = 
11.3 Hz, 1H), 3.70 (d, J = 11.4 Hz, 1H), 3.65 (s, 3H), 3.13 (d, J = 5.4 Hz, 1H), 2.65 (dd, J 
= 12.3, 4.8 Hz, 1H), 2.51–2.36 (m, 2H), 2.26–2.14 (m, 1H), 2.07 (s, 3H), 2.03–1.97 (m, 
1H), 1.99 (s, 3H), 1.23 (t, J = 7.1 Hz, 3H), 1.15 (s, 3H), 0.94 (d, J = 6.4 Hz, 3H); 13C 
NMR (101 MHz, CDCl3) δ = 174.3, 170.9, 170.8, 169.9, 143.3, 131.1, 68.8, 68.7, 60.3, 
59.5, 51.8, 49.5, 49.1, 40.5, 39.1, 34.5, 21.5, 21.1, 21.0, 14.5; HRMS (ESI) m/z calcd for 
C21H30O8Na [M + Na]+: 433.1833, found: 433.1835; 61: Rf = 0.32 (pentane/Et2O 2:1); 𝛼 #%&	= +223.8 (c 0.14, CHCl3); FTIR (neat): ν = 2957, 1725, 1454, 1372, 1320, 1222, 
1141, 1033, 793 cm-1; 1H NMR (400 MHz, CDCl3) δ = 6.22 (d, J = 10.0 Hz, 1H), 5.82 (s, 
1H), 5.58 (dd, J = 10.0, 5.1 Hz, 1H), 4.14–4.01 (m, 2H), 3.92 (d, J = 10.9 Hz, 1H), 3.74 
(d, J = 10.9 Hz, 1H), 3.65 (s, 3H), 3.15 (d, J = 5.1 Hz, 1H), 2.48–2.29 (m, 3H), 2.04 (s, 
3H), 1.22 (t, J = 7.1 Hz, 3H), 1.19 (s, 3H), 1.03 (d, J = 6.3 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ = 173.1, 171.3, 170.9, 143.3, 132.3, 129.8, 122.1, 68.3, 60.8, 59.3, 51.8, 50.2, 
47.9, 39.7, 38.8, 21.0, 19.4, 14.4, 14.3. HRMS (ESI) m/z calcd for C19H27O6 [M + H]+: 
351.1802, found: 351.1800. 
 
6-Ethyl 3a-methyl (3R,3aR,6S,7R)-5-hydroxy-7-(hydroxymethyl)-3,7-dimethyl-
2,3,4,5,6,7-hexahydro-3aH-indene-3a,6-dicarboxylate (62): The diacetyled product 60 
(38.7 mg, 94.3 µmol, 1.0 eq.) was dissolved in dry MeOH (1.5 mL), K2CO3 (53.2 mg, 
0.38 mmol, 4.0 eq.) was added and the reaction mixture was stirred at rt for 16 h. The 
reaction mixture was diluted with EtOAc (5.0 mL), aq. HCl (1 M, 2.0 mL) was added and 
the mixture was extracted with EtOAc (3 x 2.0 mL). The combined organic layers were 
washed with brine (1.5 mL), dried over Na2SO4, filtered and the solvent was removed 
under reduced pressure. The residue was purified by flash column chromatography 
(pentane/EtOAc 1:1) to afford the diol 62 (30.1 mg, 92 µmol, 98%) as colorless sticky 
oil; Rf = 0.45 (pentane/EtOAc 1:1); 𝛼 #%)	= –1.9 (c 0.25, CHCl3); FTIR (neat): ν = 3448, 
2954, 1721, 1448, 1178, 1027, 885, 780, 710, 660 cm-1; 1H NMR (400 MHz, CDCl3) δ = 
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5.86 (s, 1H), 4.20–4.04 (m, 3H), 3.70 (s, 3H), 3.20 (d, J = 11.3 Hz, 1H), 3.07 (d, J = 11.3 
Hz, 1H), 2.70–2.60 (m, 2H), 2.51–2.40 (m, 2H), 2.22–1.88 (m, 4H), 1.24 (t, J = 7.1 Hz, 
3H), 1.17 (s, 3H), 0.96 (d, J = 6.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 175.4, 
171.5, 142.5, 132.8, 66.6, 66.3, 60.4, 59.9, 54.3, 52.2, 48.6, 43.0, 39.0, 37.8, 21.4, 14.7, 
14.4; HRMS (ESI) m/z calcd for C17H26O6Na [M + Na]+: 349.1622, found: 349.1626. 
 
6-Ethyl 3a-methyl (3R,3aR,7S)-7-formyl-5-hydroxy-3,7-dimethyl-2,3,4,7-tetrahydro-3aH-
indene-3a,6-dicarboxylate (63): To a flask charged with flame dried molecular sieves (4 
Å, 120 mg) was added a solution of the diol 62 (58.1 mg, 178 µmol, 1.0 eq.) in dry 
CH2Cl2 (5.0 mL). NMO (56.0 mg, 0.46 mmol, 2.6 eq.) was added at rt and the reaction 
mixture was stirred for 20 min. TPAP (12.9 mg, 35 µmol, 0.2 eq.) was added and the 
solution was stirred at rt for 24 h, while the color turned from green to dark blue. The 
reaction mixture was filtered over celite and the solvent was removed under reduced 
pressure. The residue was purified by flash column chromatography (pentane/Et2O 3:1) to 
yield the enol 63 (39.0 mg, 0.12 mmol, 68%) as colorless oil; Rf = 0.39 (pentane/Et2O 
3:1); 𝛼 #%)	= –124.9 (c 0.61, CHCl3); FTIR (neat): ν = 2960, 2934, 2848, 1728, 1642, 
1607, 1458, 1402, 1297, 1228, 1076, 863, 732, 631 cm-1; 1H NMR (400 MHz, CDCl3) δ = 
12.94 (s, 1H), 9.13 (s, 1H), 5.98 (s, 1H), 4.27–4.12 (m, 2H), 3.63 (s, 3H), 3.25 (d, J = 
16.4 Hz, 1H), 2.54 (ddd, J = 15.3, 7.3, 3.1 Hz, 1H), 2.37–2.19 (m, 2H), 2.16 (d, J = 16.3 
Hz, 1H), 1.47 (s, 3H), 1.23 (t, J = 7.1 Hz, 3H), 1.02 (d, J = 6.9 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ = 197.3, 175.8, 172.8, 171.5, 141.3, 133.3, 99.0, 61.1, 60.2, 51.9, 50.8, 
46.4, 39.8, 38.9, 22.7, 15.0, 14.1; HRMS (ESI) m/z calcd for C17H23O6 [M + H]+: 
323.1489, found: 323.1490. 
 
6-Ethyl 3a-methyl (3R,3aR,7S)-7-formyl-6-hydroxy-3,7-dimethyl-5-oxo-2,3,4,5,6,7-hexa-
hydro-3aH-indene-3a,6-dicarboxylate (64):  The enol 63 (89.0 mg, 276 µmol, 1.0 eq.) 
was dissolved in dry i-PrOH (5 mL), then degassed (freeze-thaw method, 2 cycles) and 
refilled with oxygen. CeCl3 · 7 H2O (105 mg, 276 µmol, 1.0 eq.) was added at rt and 
oxygen was bubbled through the colorless solution for 15 min. The solution was stirred 
under oxygen atmosphere at rt for 20 h. Dist. water (5 mL) was added, the mixture was 
extracted with EtOAc (3 x 5 mL), the combined organic layers were washed with brine (3 
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mL), dried over Na2SO4, filtered and the solvent was removed under reduced pressure. 
The crude was purified by flash column chromatography (pentane/Et2O 2:1) to afford the 
α-hydroxylated product 64 (40 mg, 119 µmol, 43%) as colorless oil; Rf = 0.37 
(pentane/Et2O 1:1); 𝛼 #%)	= –68.8 (c 0.53, CHCl3); FTIR (neat): ν = 3454, 2959, 1724, 
1453, 1373, 1217, 1162, 1099, 1001, 916, 859, 732, 653 cm-1; 1H NMR (400 MHz, 
CDCl3) δ = 9.40 (s, 1H), 6.11 (s, 1H), 4.31 (q, J = 7.1 Hz, 2H), 3.91 (s, 1H), 3.64 (s, 3H), 
3.51 (d, J = 14.7 Hz, 1H), 2.84 (d, J = 14.7 Hz, 1H), 2.59–2.45 (m, 2H), 2.32–2.20 (m, 
1H), 1.40 (s, 3H), 1.28 (t, J = 7.2 Hz, 3H), 0.98 (d, J = 6.7 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ = 202.8, 197.3, 172.5, 170.4, 138.8, 135.1, 82.9, 63.8, 61.1, 58.7, 52.2, 50.6, 
44.4, 39.3, 14.6, 14.5, 14.1; HRMS (ESI) m/z calcd for C17H23O7 [M + H]+: 339.1438, 
found: 339.1441. 
 
(3aR,4R,6aR,7R,9bR)-3a-Hydroxy-7,9b-dimethyl-1,3a,4,7,8,9b-hexahydro-3H,6H-4,6a-
methanocyclopenta[c]furo[3,4-e]oxepine-3,6-dione (65):  The α-hydroxylated ketone 64 
(21.3 mg, 63.0 µmol, 1.0 eq.) was dissolved in dry MeOH (1.0 mL) and cooled to 0 °C. 
NaBH4 (11.9 mg, 315 µmol, 5.0 eq.) was added in small portions and the reaction mixture 
was allowed to warm up to rt over 11 h. The reaction mixture was cooled to 0 °C and dist. 
water (1.5 mL) was added. The aq. layer was extracted with EtOAc (4 x 1.5 mL), dried 
over Na2SO4, filtered and the solvent was removed under reduced pressure to afford the 
crude diol as colorless solid. The crude diol (21 mg, 70.9 µmol, 1.0 eq.) was dissolved in 
dry toluene (1.0 mL) and p-toluensulfonic acid monohydrate (2.7 mg, 14.2 µmol, 0.2 eq.) 
was added. The reaction mixture was stirred at 77 °C for 2 h. The reaction mixture was 
diluted with EtOAc (3 mL) and washed with aq. sat. NaHCO3 solution (2.0 mL). The aq. 
layer was extracted with EtOAc (3 x 1.5 mL), the combined organic layers was washed 
with brine (1.5 mL), dried over Na2SO4, filtered and the solvent was removed under 
reduced pressure. The residue was purified by flash column chromatography 
(pentane/EtOAc 3:1) to afford the dilactone 65 (4.4 mg, 17 µmol, 27%, over two steps) as 
white solid; Mp: 129.5–130.2 °C; Rf = 0.53 (pentane/EtOAc 2:1); 𝛼 #%)	= +75.0 (c 0.47, 
CHCl3); FTIR (neat): ν = 3448, 2921, 2851, 1782, 1753, 1457, 1376, 1326, 1221, 1185, 
1113, 1016, 1000, 938, 818, 732, 639 cm-1; 1H NMR (400 MHz, CDCl3) δ = 5.87 (s, 1H), 
4.63 (d, J = 5.9 Hz, 1H), 3.98 (q, J = 9.5 Hz, 2H), 2.58 (ddd, J = 15.6, 8.1, 2.9 Hz, 1H), 
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2.48 (dd, J = 11.9, 5.9 Hz, 1H), 2.44–2.37 (m, 1H), 2.32 (ddd, J = 15.5, 9.7, 1.9 Hz, 1H), 
2.21 (d, J = 12.1 Hz, 1H), 1.36 (s, 3H), 1.32 (d, J = 6.9 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ = 177.7, 174.9, 140.6, 129.8, 78.9, 78.0, 74.4, 56.6, 43.3, 39.2, 37.0, 35.0, 21.4, 
13.3; HRMS (ESI) m/z calcd for C14H16O5Na [M + Na]+: 287.0890, found: 287.0894. 
 
Supporting Information 
Reaction conditions for the oxidation of compound 33. 1H- and 13C-NMR spectra. X-
Ray crystal structure analysis data. 
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